BENVENISTE lab

Inflammatory Myopathies & Innovative Therapies

Myositis are autoimmune diseases that affects the muscles and are often associated with extra-muscular involvement (e.g., skin, joints, or lungs). Thus, myositis is a group of disorders that either involve only the muscles or are systemic diseases. These conditions can be spontaneous or triggered by cancer and/or treatments (e.g., cholesterol-lowering drugs or cancer immunotherapies). They are serious diseases that can lead to disability or even be life-threatening. Treatment combines usually corticosteroids and immunosuppressants, but without targeted approaches and without considering the specificities of myositis subgroups.

Our objective is to improve the diagnostic and therapeutic management of myositis.

Our approach is translational: from the laboratory to the patient and from the patient back to the laboratory.

Our team consists of expert physicians/researchers in myositis, research engineers, biostaticians, doctoral candidates, and postdoctoral fellows.

We have established a biobank containing biological samples from over 1,500 myositis patients, alongside associated medical data. In our laboratory, we have an outstanding research environment focused on muscle and autoimmune diseases, allowing for the analysis of samples and in vitro experimentation, particularly using muscle cell culture models, to achieve our aims.

Our research focuses on three main areas:

(i) Defining homogeneous patient groups, (ii) analyzing at the tissue-level pathophysiological mechanisms, and (iii) developing innovative diagnostic and therapeutic tools.

 1- Nosological framework : Identify your opponents

As a prerequisite for any research work, it is necessary to define homogeneous patient groups with common pathomechanisms.

Over the last 10 years, we have been at the forefront of revising the international diagnostic criteria for the main subgroups of myositis (dermatomyositis, immune-mediated necrotizing myopathy, and anti-synthetase syndrome). We have demonstrated, with others, the crucial role of myositis specific antibodies to diagnose and classify myositis patients into homogeneous groups and organized conference consensus on the detection methods for myositis specific autoantibodies (ENMC 2021 criteria). We also contributed to the workshop refining the diagnosis criteria for inclusion body myositis (ENMC 2023 criteria).

We were also pioneers in describing a new subgroup of myositis induced by immune checkpoint inhibitors (ICIs), whose use represents a major advancement in cancer treatment. We have reported the largest series of ICI-induced myositis, demonstrating that the disease differs from spontaneous myositis in terms of phenotype and high mortality rate.  Indeed, in recent years, a new form of myositis has emerged combining severe muscle and heart manifestations. Naturally, our team has expanded with the addition of a world-renowned cardiologist expert (Pr Salem) in the cardiac toxicity of anti-cancer drugs and myocarditis induced by anti-tumor immunotherapy.

2- Clarify the pathomechanism: Identify the weaknesses of your opponent

We have contributed to demonstrating the pathogenic role of autoantibodies in myositis, particularly in the most disabling form, immune-mediated necrotizing myopathy. We were also pioneers in demonstrating the pathogenic role of type I interferon in dermatomyositis.

These studies led us to closely analyze the characteristics of muscle inflammation in tissue, and, more importantly, its effect on muscle fibers.

To improve our understanding, we had to develop and learn to use RNA sequencing tools at the single-nucleus or single-cell level, using enzymatically digested tissue, but also preserving tissue architecture (spatial transcriptomics) in order to analyze cellular interactions. These extensive molecular data need to be validated at the protein level. Therefore, we have established multiplex imaging analyses using Imaging Mass Cytometry (Hyperion®) or are conducting international collaborations for mass spectrometry analyses.

These studies allowed us to understand the pathophysiological mechanisms of myositis induced by immunotherapy, highlighting the important role of resident immune cells in the muscle.

These techniques also enabled us to demonstrate the significance of non-inflammatory resident cells in muscle tissue in the pathological mechanisms and their impact on muscle cell regeneration. These results lead us to analyze the effect of inflammation on the muscle microenvironment by testing hypotheses using 3D culture models.

3- Develop a new therapeutic strategy: Defeat one’s enemy

From the laboratory, we return to the patients to propose therapeutic solutions.

Over the past 10 years, our research has led to innovative controlled clinical trials (academic or industrial) for each subgroup of myositis: inclusion body myositis, necrotizing autoimmune myopathies, anti-synthetase syndrome, and dermatomyositis. As exemple, in dermatomyositis anti-interferon approaches using JAK inhibitors are tested in a randomized control trial (PHRC 2018; PI Y. Allenbach).

The studies we conducted also led to developments abroad, such as the international phase III trial testing rapamycin in inclusion body myositis (NCT04789070).

Among the latest advancements we are working on, we are proposing an innovative therapy to treat the muscular and cardiac complications of immunotherapy, as well as studies in regenerative medicine through cell therapy for inclusion body myositis.

We recently proposed to restore muscle strength using cell therapy with the stromal vascular fraction (rich in stem cells). This cell extract obtained from adipose tissue can differentiate into several lineages, including muscle tissue. We were awarded a grant (PHRC-N 2018; NCT05032131 PI O. Benveniste) to conduct a Phase I clinical trial to test the effect of injecting patients with non-dominant inclusion arm myositis with their autologous stromal vascular fraction cells obtained from adipose tissue (after liposuction).

We have shown that CTLA4-Ig (Abatacept) can help patients with severe concomitant myositis and myocarditis (Salem 2023). A therapeutic trial is currently ongoing (NCT05195645, PI JE Salem) to test Abatacept in an RCT for patients with severe irAE.

Equipe Benveniste
Olivier Benveniste
Yves Allenbach

NamePositionEmailORCID



387 documents

Journal articles

  • Amélie Bourhis, Marie Robin, Stéphanie Nguyen, Arnaud Uguen, Patrice Hemon, et al.. Myopathy related to chronic Graft‐Versus‐Host Disease: From clinic to histological & immunological characterization by imaging mass cytometry. American Journal of Hematology, 2024, ⟨10.1002/ajh.27294⟩. ⟨hal-04574048⟩
  • Charlotte Fenioux, Baptiste Abbar, Samia Boussouar, Marie Bretagne, John Power, et al.. Publisher Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis. Nature Medicine, 2024, ⟨10.1038/s41591-023-02771-0⟩. ⟨hal-04414859⟩
  • Charlotte Fenioux, Baptiste Abbar, Samia Boussouar, Marie Bretagne, John Power, et al.. Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis. Nature Medicine, 2023, 29 (12), pp.3100-3110. ⟨10.1038/s41591-023-02591-2⟩. ⟨hal-04510220⟩
  • Luce Barbat Du Closel, Nathalie Bonello-Palot, Yann Pereon, Andoni Echaniz-Laguna, Jean Philippe Camdessanche, et al.. Clinical and electrophysiological characteristics of women with X-linked Charcot-Marie-Tooth disease. European Journal of Neurology, 2023, 30 (10), pp.3265-3276. ⟨10.1111/ene.15937⟩. ⟨hal-04254200⟩
  • Lorenz H. Lehmann, Markus B. Heckmann, Guillaume Bailly, Daniel Finke, Adrien Procureur, et al.. Cardiomuscular biomarkers in the diagnosis and prognostication of immune checkpoint Inhibitor myocarditis. Circulation, 2023, 148 (6), pp.473-486. ⟨10.1161/CIRCULATIONAHA.123.062405⟩. ⟨hal-04573185⟩
  • Joe-Elie Salem, Marie Bretagne, Baptiste Abbar, Sarah Leonard-Louis, Stéphane Ederhy, et al.. Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis. Cancer Discovery, 2023, 13 (5), pp.1100-1115. ⟨10.1158/2159-8290.CD-22-1180⟩. ⟨hal-04578810⟩
  • Tanya Stojkovic, Marion Masingue, Helène Turmel, Marianne Hezode-Arzel, Anthony Béhin, et al.. Diagnostic yield of a practical electrodiagnostic protocol discriminating between different congenital myasthenic syndromes. Neuromuscular Disorders, 2022, 32 (11-12), pp.870-878. ⟨10.1016/j.nmd.2022.10.001⟩. ⟨hal-04074000⟩
  • Océane Landon-Cardinal, Perrine Guillaume-Jugnot, Ségolène Toquet, Nabiha Sbeih, Aude Rigolet, et al.. JAK inhibitors for the treatment of adult dermatomyositis: A pilot study. Journal of The American Academy of Dermatology, 2022, ⟨10.1016/j.jaad.2022.10.055⟩. ⟨hal-03996988⟩
  • Alexandrine Mahoudeau, Céline Anquetil, Nozomu Tawara, Hossein Khademian, Damien Amelin, et al.. Myostatin in idiopathic inflammatory myopathies: Serum assessment and disease activity. Neuropathology and Applied Neurobiology, 2022, ⟨10.1111/nan.12849⟩. ⟨hal-03830849⟩
  • Debora Pehl, Corinna Preuße, Yves Allenbach, Olivier Benveniste, Philipp Dittert, et al.. Eosinophilic fasciitis (Shulman syndrome)—recognition of the histological spectrum allows for new insights into possible pathomechanisms. Rheumatology, 2022, ⟨10.1093/rheumatology/keac526⟩. ⟨hal-03830836⟩
  • Paul Breillat, Kuberaka Mariampillai, Paul Legendre, Pauline Martins, Bertrand Dunogue, et al.. Anti-PM-Scl antibodies–positive patients encompass three different groups with distinct prognoses. Rheumatology, 2022, ⟨10.1093/rheumatology/keac508⟩. ⟨hal-03830880⟩
  • Sarah Julien, Douangsone Vadysirisack, Camil Sayegh, Sharan Ragunathan, Yalan Tang, et al.. Prevention of Anti-HMGCR Immune-Mediated Necrotising Myopathy by C5 Complement Inhibition in a Humanised Mouse Model. Biomedicines, 2022, 10 (8), pp.2036. ⟨10.3390/biomedicines10082036⟩. ⟨hal-03830885⟩
  • Corinna Preuße, Barbara Paesler, Christopher Nelke, Derya Cengiz, Thomas Müntefering, et al.. Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositis. Acta Neuropathologica, 2022, 144 (2), pp.353-372. ⟨10.1007/s00401-022-02438-z⟩. ⟨hal-03830925⟩
  • Antoine Soulages, Thierry Maisonobe, Pascal Auzou, Antoine Petit, Yves Allenbach, et al.. Peripheral neuropathy and livedoid vasculopathy. Journal of Neurology, 2022, 269 (7), pp.3779-3788. ⟨10.1007/s00415-022-11007-z⟩. ⟨hal-03832490⟩
  • Jan Damoiseaux, Andrew Mammen, Yves Piette, Olivier Benveniste, Yves Allenbach. 256th ENMC international workshop: Myositis specific and associated autoantibodies (MSA-ab): Amsterdam, The Netherlands, 8-10 October 2021. Neuromuscular Disorders, 2022, 32 (7), pp.594-608. ⟨10.1016/j.nmd.2022.05.011⟩. ⟨hal-03830916⟩
  • Corinna Preusse, Theodore Marteau, Norina Fischer, Andreas Hentschel, Albert Sickmann, et al.. Endoplasmic reticulum‐stress and unfolded protein response‐activation in immune‐mediated necrotizing myopathy. Brain Pathology, 2022, ⟨10.1111/bpa.13084⟩. ⟨hal-03830912⟩
  • Caoilfhionn Connolly, Lotta Plomp, Julie Paik, Yves Allenbach. Possible future avenues for myositis therapeutics: DM, IMNM and IBM. Best Practice and Research: Clinical Rheumatology, 2022, 36 (2), pp.101762. ⟨10.1016/j.berh.2022.101762⟩. ⟨hal-03832475⟩
  • Pierre Bay, Marc Pineton de Chambrun, Antoine Roux, Vincent Bunel, Alain Combes, et al.. Extracorporeal life support allows lung transplant in anti-MDA5+ rapidly progressive interstitial lung disease. European Respiratory Journal, 2022, 59 (5), pp.2102968. ⟨10.1183/13993003.02968-2021⟩. ⟨hal-03832484⟩
  • Amandine Laporte, Kubéraka Mariampillai, Yves Allenbach, Nicoletta Pasi, Victoria Donciu, et al.. Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies. European Radiology, 2022, 32 (5), pp.3480-3489. ⟨10.1007/s00330-021-08411-w⟩. ⟨hal-03830934⟩
  • Lee Nguyen, Marie Bretagne, Jennifer Arrondeau, Noel Zahr, Stephane Ederhy, et al.. Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept. Journal for Immunotherapy of Cancer, 2022, 10 (4), pp.e004699. ⟨10.1136/jitc-2022-004699⟩. ⟨hal-04002766⟩
  • Lee Nguyen, Marie Bretagne, Jennifer Arrondeau, Noel Zahr, Stephane Ederhy, et al.. Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept. Journal for Immunotherapy of Cancer, 2022, 10 (4), pp.e004699. ⟨10.1136/jitc-2022-004699⟩. ⟨hal-03832478⟩
  • Wladimir Mauhin, Abdellah Tebani, Damien Amelin, Lenaig Abily-Donval, Foudil Lamari, et al.. Sphingosine-1-Phosphate Levels Are Higher in Male Patients with Non-Classic Fabry Disease. Journal of Clinical Medicine, 2022, 11 (5), pp.1233. ⟨10.3390/jcm11051233⟩. ⟨hal-03830929⟩
  • Stéphane Ederhy, Perrine Devos, Bruno Pinna, Elisa Funck-Brentano, Baptiste Abbar, et al.. 8 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography imaging for the diagnosis of immune checkpoint inhibitors associated myocarditis. Archives of cardiovascular diseases, 2022, ⟨10.1016/j.acvd.2021.12.001⟩. ⟨hal-03561783⟩
  • Pierre Bay, Marc de Chambrun, Vincent Rothstein, Matthiéu Mahevas, Nicolas de Prost, et al.. Efficacy of plasma exchange in patients with anti-MDA5 rapidly progressive interstitial lung disease. Journal of Autoimmunity, 2022, 133, ⟨10.1016/j.jaut.2022.102941⟩. ⟨hal-03950145⟩
  • Xavier Mariette, Olivier Hermine, Pierre-Louis Tharaux, Matthieu Resche-Rigon, Raphael Porcher, et al.. Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial. The Lancet Rheumatology, 2022, 4 (1), pp.e24-e32. ⟨10.1016/S2665-9913(21)00315-5⟩. ⟨hal-03783213⟩
  • Joe-Elie Salem, Nadjib Hammoudi, Bruno Pinna, Stephane Ederhy, Antonin Lamazière, et al.. Echocardiography and renin-aldosterone interplay as predictors of death in COVID-19. Archives of cardiovascular diseases, In press, ⟨10.1016/j.acvd.2021.11.006⟩. ⟨hal-03572401⟩
  • Carolien Bonroy, Yves Piette, Yves Allenbach, Xavier Bossuyt, Jan Damoiseaux. Positioning of myositis-specific and associated autoantibody (MSA/MAA) testing in disease criteria and routine diagnostic work-up. Journal of Translational Autoimmunity, 2022, 5, pp.100148. ⟨10.1016/j.jtauto.2022.100148⟩. ⟨hal-03832479⟩
  • Gorka Fernández-Eulate, Rabab Debs, Thierry Maisonobe, Philippe Latour, Fleur Cohen-Aubart, et al.. Sjögren syndrome and RFC1-CANVAS sensory ganglionopathy: co-occurrence or misdiagnosis?. Journal of Neurology, 2022, ⟨10.1007/s00415-022-11382-7⟩. ⟨hal-03830863⟩
  • Bonny Rockette-Wagner, Didem Saygin, Siamak Moghadam-Kia, Chester Oddis, Océane Landon-Cardinal, et al.. Reliability, validity and responsiveness of physical activity monitors in patients with inflammatory myopathy. Rheumatology, 2021, 60 (12), pp.5713-5723. ⟨10.1093/rheumatology/keab236⟩. ⟨hal-03832520⟩
  • Franck Phan, Samia Boussouar, Olivier Lucidarme, Mohamed Zarai, Joe-Elie Salem, et al.. Cardiac adipose tissue volume and IL-6 level at admission are complementary predictors of severity and short-term mortality in COVID-19 diabetic patients. Cardiovascular Diabetology, 2021, 20, pp.165. ⟨10.1186/s12933-021-01327-1⟩. ⟨hal-03346419⟩
  • Nadège Cordel, Céline Derambure, Sophie Coutant, Xavier Mariette, Denis Jullien, et al.. TRIM33 gene somatic mutations identified by next generation sequencing in neoplasms of patients with anti-TIF1γ positive cancer-associated dermatomyositis. Rheumatology, 2021, 60 (12), pp.5863-5867. ⟨10.1093/rheumatology/keab260⟩. ⟨hal-03667247⟩
  • Helena Costa-Verdera, Fanny Collaud, Christopher R Riling, Pauline Sellier, Jayme M L Nordin, et al.. Hepatic expression of GAA results in enhanced enzyme bioavailability in mice and non-human primates. Nature Communications, 2021, 12 (1), pp.6393. ⟨10.1038/s41467-021-26744-4⟩. ⟨hal-03449262⟩
  • John R Power, Joachim Alexandre, Arrush Choudhary, Benay Ozbay, Salim Hayek, et al.. Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis. Circulation, 2021, 144 (18), pp.1521-1523. ⟨10.1161/CIRCULATIONAHA.121.055816⟩. ⟨hal-03414602⟩
  • Rocio Nur Villar-Quiles, Norma B Romero, Stojkovic Tanya. Dystrophie musculaire liée à des mutations du gène JAG2 : l'importance du diagnostic différentiel. Médecine/Sciences, 2021, 37, pp.40-43. ⟨10.1051/medsci/2021191⟩. ⟨hal-03475173⟩
  • Lorenz Lehmann, Jennifer Cautela, Nicolas Palaskas, Alan Baik, Wouter Meijers, et al.. Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor–Associated Myocarditis. JAMA Cardiology, 2021, 6 (11), pp.1329. ⟨10.1001/jamacardio.2021.2241⟩. ⟨hal-03654644⟩
  • Marc Pawlitzki, Christopher Nelke, Leoni Rolfes, Rebecca Hasseli, Stylianos Tomaras, et al.. NK Cell Patterns in Idiopathic Inflammatory Myopathies with Pulmonary Affection. Cells, 2021, 10 (10), pp.2551. ⟨10.3390/cells10102551⟩. ⟨hal-03369634⟩
  • Antoine Marchiset, Mathilde Neuville, Guillaume Voiriot, Julien de Wolf, Matthieu Glorion, et al.. High-Emergency Lung Transplantation for Interstitial Lung Disease Associated With Anti-MDA5 Dermatomyositis: A Case Report. Transplantation Proceedings, 2021, 53 (8), pp.2613-2615. ⟨10.1016/j.transproceed.2021.08.012⟩. ⟨hal-04463966⟩
  • Antoine Marchiset, Mathilde Neuville, Guillaume Voiriot, Julien de Wolf, Matthieu Glorion, et al.. High-Emergency Lung Transplantation for Interstitial Lung Disease Associated With Anti-MDA5 Dermatomyositis: A Case Report. Transplantation Proceedings, 2021, 53 (8), pp.2613-2615. ⟨10.1016/j.transproceed.2021.08.012⟩. ⟨hal-03832502⟩
  • Franklin Ducatez, Wladimir Mauhin, Agnès Boullier, Carine Pilon, Tony Pereira, et al.. Parsing Fabry Disease Metabolic Plasticity Using Metabolomics. Journal of Personalized Medicine, 2021, 11 (9), pp.898. ⟨10.3390/jpm11090898⟩. ⟨hal-03366297⟩
  • B. Lioger, C. Le Pendu, W. Mounfaloti, Yves Allenbach. [Rhabdomyolysis and anemia in a 25 year-old man].. La Revue de Médecine Interne, 2021, 42 (9), pp.669-671. ⟨10.1016/j.revmed.2021.08.007⟩. ⟨hal-03832510⟩
  • Marion Quirins, Marie Théaudin, Fleur Cohen-Aubart, Alain Créange, Luc Mouthon, et al.. Nonsystemic vasculitic neuropathy: Presentation and long-term outcome from a French cohort of 50 patients. Autoimmunity Reviews, 2021, 20 (8), pp.102874. ⟨10.1016/j.autrev.2021.102874⟩. ⟨hal-03830977⟩
  • Noël Zahr, Saik Urien, Benoit Llopis, Valérie Pourcher, Olivier Paccoud, et al.. Pharmacokinetics and pharmacodynamics of hydroxychloroquine in hospitalized patients with COVID-19. Therapies, 2021, 76 (4), pp.285-295. ⟨10.1016/j.therap.2021.01.056⟩. ⟨hal-04073526⟩
  • Nguyen Thi Huong, Rocio-Nur Villar-Quiles, Van Thuy Le, Sarah Leonard-Louis, Lilia Laddada, et al.. Leukoencephalopathy and conduction blocks in PLEKHG5-associated intermediate CMT disease. Neuromuscular Disorders, 2021, ⟨10.1016/j.nmd.2021.06.004⟩. ⟨hal-03285057⟩
  • Marion Peyre, Noel Zahr, Quentin Riller, Fleur Cohen-Aubart, Yves Allenbach, et al.. Mycophenolic acid area under the curve in patients with inflammatory myopathies. Rheumatology, 2021, 60 (6), pp.3026-3028. ⟨10.1093/rheumatology/keab167⟩. ⟨hal-03830972⟩
  • Charlotte Fenioux, Yves Allenbach, Aurore Vozy, Joe-Élie Salem, Georgina Maalouf, et al.. Comparaison des caractéristiques et des pronostics des patients avec et sans cancer actif hospitalisés pour une infection à SARS-CoV-2. Bulletin du Cancer, 2021, 108 (6), pp.581-588. ⟨10.1016/j.bulcan.2021.03.004⟩. ⟨hal-03830953⟩
  • François Fer, Y. Allenbach, Olivier Benveniste. La revue de médecine interne Myosites: de la classification au diagnostic. La Revue de Médecine Interne, 2021, 42 (6), pp.392-400. ⟨10.1016/j.revmed.2020.10.379⟩. ⟨hal-03577137⟩
  • Harmen Reyngoudt, Benjamin Marty, Jean-Marc Boisserie, Julien Le Louër, Cedi Koumako, et al.. Global versus individual muscle segmentation to assess quantitative MRI-based fat fraction changes in neuromuscular diseases. European Radiology, 2021, 31 (6), pp.4264-4276. ⟨10.1007/s00330-020-07487-0⟩. ⟨hal-03830984⟩
  • A Nguyen, Y Repesse, M Ebbo, Y Allenbach, Olivier Benveniste, et al.. IVIg increases interleukin-11 levels, which in turn contribute to increased platelets, VWF and FVIII in mice and humans. Clinical and Experimental Immunology, 2021, 204 (2), pp.258-266. ⟨10.1111/cei.13580⟩. ⟨hal-03830962⟩
  • Corinna Preusse, Pascale Eede, Lucie Heinzeling, Kiara Freitag, Randi Koll, et al.. NanoString technology distinguishes anti‐TIF‐1γ + from anti‐Mi‐2 + dermatomyositis patients. Brain Pathology, 2021, 31 (3), ⟨10.1111/bpa.12957⟩. ⟨hal-03244148⟩
  • Loïs Bolko, Wei Jiang, Nozomu Tawara, Océane Landon-Cardinal, Céline Anquetil, et al.. The role of interferons type I, II and III in myositis: A review. Brain Pathology, 2021, 31 (3), pp.e12955. ⟨10.1111/bpa.12955⟩. ⟨hal-03242856⟩
  • Samuel Malartre, Damien Bachasson, Guillaume Mercy, Elissone Sarkis, Céline Anquetil, et al.. MRI and muscle imaging for idiopathic inflammatory myopathies. Brain Pathology, 2021, 31 (3), pp.e12954. ⟨10.1111/bpa.12954⟩. ⟨hal-03242994⟩
  • Ségolène Toquet, Benjamin Granger, Yurdagul Uzunhan, Kubéraka Mariampillai, Hilario Nunes, et al.. The seasonality of Dermatomyositis associated with anti-MDA5 antibody: An argument for a respiratory viral trigger. Autoimmunity Reviews, 2021, 20 (4), pp.102788. ⟨10.1016/j.autrev.2021.102788⟩. ⟨hal-03830990⟩
  • Anthony Amato, Michael Hanna, Pedro Machado, Umesh Badrising, Hector Chinoy, et al.. Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis. Neurology, 2021, 96 (12), pp.e1595-e1607. ⟨10.1212/WNL.0000000000011626⟩. ⟨hal-03830946⟩
  • Pierre-Louis Tharaux, Gilles Pialoux, Arthur Pavot, Xavier Mariette, Olivier Hermine, et al.. Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial. The Lancet Respiratory Medicine, 2021, 9 (3), pp.295-304. ⟨10.1016/S2213-2600(20)30556-7⟩. ⟨hal-03579180⟩
  • Brian R Long, Philippe Veron, Klaudia Kuranda, Romain Hardet, Nina Mitchell, et al.. Early Phase Clinical Immunogenicity of Valoctocogene Roxaparvovec, an AAV5-Mediated Gene Therapy for Hemophilia A. Molecular Therapy, 2021, 29 (2), pp.597-610. ⟨10.1016/j.ymthe.2020.12.008⟩. ⟨hal-03200117⟩
  • Arthur Geraud, Paul Gougis, Aurore Vozy, Celine Anquetil, Yves Allenbach, et al.. Clinical Pharmacology and Interplay of Immune Checkpoint Agents: A Yin-Yang Balance. Annual Review of Pharmacology and Toxicology, 2021, 61 (1), ⟨10.1146/annurev-pharmtox-022820-093805⟩. ⟨hal-02949235⟩
  • Matheus Vieira, Georgina Maalouf, Milena Hasan, Alexandre Le Joncour, Esma Karkeni, et al.. Cytokine profile as a prognostic tool in coronavirus disease 2019. Comment on “Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome”. Joint Bone Spine, 2021, 88 (1), pp.105074. ⟨10.1016/j.jbspin.2020.09.006⟩. ⟨hal-03099645⟩
  • Olivier Benveniste, Jean-Yves Hogrel, Lisa Belin, Mélanie Annoussamy, Damien Bachasson, et al.. Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial. The Lancet Rheumatology, 2021, 3 (1), pp.e40-e48. ⟨10.1016/S2665-9913(20)30280-0⟩. ⟨hal-03180889⟩
  • Marita Chakhtoura, Mike Fang, Rafael Cubas, Margaret H O’connor, Carmen N Nichols, et al.. Germinal Center T follicular helper (GC-Tfh) cell impairment in chronic HIV infection involves c-Maf signaling. PLoS Pathogens, 2021, 17 (7), pp.e1009732. ⟨10.1371/journal.ppat.1009732⟩. ⟨hal-03292792⟩
  • Noel Zahr, Saïk Urien, Benoit Llopis, Valerie Pourcher, Olivier Paccoud, et al.. Pharmacokinetics and pharmacodynamics of hydroxychloroquine in hospitalized patients with COVID-19. Alternative and Complementary Therapies, In press, ⟨10.1016/j.therap.2021.01.056⟩. ⟨hal-03127389⟩
  • Michaël Guetta, Aurélie Kas, Aveline Aouidad, Marine Soret, Yves Allenbach, et al.. Relevance of Brain 18F-FDG PET Imaging in Probable Seronegative Encephalitis With Catatonia: A Case Report. Frontiers in Psychiatry, 2021, 12, pp.685711. ⟨10.3389/fpsyt.2021.685711⟩. ⟨hal-03274512⟩
  • Olivier Hermine, Xavier Mariette, Pierre-Louis Tharaux, Matthieu Resche-Rigon, Raphaël Porcher, et al.. Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia. JAMA Internal Medicine, 2021, 181 (1), pp.32-40. ⟨10.1001/jamainternmed.2020.6820⟩. ⟨hal-03579175⟩
  • Océane Landon-Cardinal, Cédi Koumako, Giulia Hardouin, Benjamin Granger, Harmen Reyngoudt, et al.. Severe axial and pelvifemoral muscle damage in immune-mediated necrotizing myopathy evaluated by whole-body MRI. Seminars in Arthritis and Rheumatism, 2020, 50, pp.1437 - 1440. ⟨10.1016/j.semarthrit.2020.02.009⟩. ⟨hal-03494062⟩
  • Damien Bachasson, Alper Carras Ayaz, Jessie Mosso, Aurélie Canal, Jean-Marc Boisserie, et al.. Lean regional muscle volume estimates using explanatory bioelectrical models in healthy subjects and patients with muscle wasting. Journal of Cachexia, Sarcopenia and Muscle, 2020, 12 (1), pp.39-51. ⟨10.1002/jcsm.12656⟩. ⟨hal-03146449⟩
  • Adam Celier, Yves Allenbach, Céline Anquetil, Fabrizio Andreelli, Anne Bachelot, et al.. Toxicités sévères immuno-induites par les inhibiteurs de points de contrôle immunitaire : implications pour le réanimateur. Médecine Intensive Réanimation, 2020, ⟨10.37051/mir-00046⟩. ⟨hal-03832598⟩
  • Marie Kostine, Axel Finckh, Clifton Bingham, Karen Visser, Jan Leipe, et al.. EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors. Annals of the Rheumatic Diseases, 2020, 80 (1), pp.36-48. ⟨10.1136/annrheumdis-2020-217139⟩. ⟨hal-03832523⟩
  • Yves Allenbach, Olivier Benveniste, Werner Stenzel, Olivier Boyer. Immune-mediated necrotizing myopathy: clinical features and pathogenesis. Nature Reviews Rheumatology, 2020, 16 (12), pp.689-701. ⟨10.1038/s41584-020-00515-9⟩. ⟨hal-03831009⟩
  • Grégoire Monseau, Stéphane Barete, Agathe Masseau, Alain Meyer, Benjamin Terrier, et al.. Systematic retrospective study of 64 patients with anti-Mi2 dermatomyositis: A classic skin rash with a necrotizing myositis and high risk of malignancy. Journal of The American Academy of Dermatology, 2020, 83 (6), pp.1759-1763. ⟨10.1016/j.jaad.2020.03.058⟩. ⟨hal-03523438⟩
  • Alexandre Le Joncour, Corinne Frere, Isabelle Martin-Toutain, Paul Gougis, Pascale Ghillani-Dalbin, et al.. Antiphospholipid antibodies and thrombotic events in COVID-19 patients hospitalized in medicine ward. Autoimmunity Reviews, 2020, pp.102729. ⟨10.1016/j.autrev.2020.102729⟩. ⟨hal-03101393⟩
  • Grégoire Monseau, Océane Landon-Cardinal, Anne-Marie Bouvier, Valérie Jooste, Achille Aouba, et al.. Response to: Comment on “Systematic retrospective study on 64 patients anti-Mi2 dermatomyositis: A classic skin rash with a necrotizing myositis and high risk of malignancy”. Journal of The American Academy of Dermatology, 2020, 83 (6), pp.e461-e462. ⟨10.1016/j.jaad.2020.07.110⟩. ⟨hal-03831099⟩
  • Tiphaine Lenfant, Sawsen Salah, Gaëlle Leroux, Elodie Bousquet, Véronique Le Guern, et al.. Risk factors for hydroxychloroquine retinopathy in systemic lupus erythematosus: a case–control study with hydroxychloroquine blood-level analysis. Rheumatology, 2020, 59 (12), pp.3807-3816. ⟨10.1093/rheumatology/keaa157⟩. ⟨hal-03831064⟩
  • Yves Allenbach, David Saadoun, Georgina Maalouf, Matheus Vieira, Alexandra Hellio, et al.. Development of a multivariate prediction model of intensive care unit transfer or death: A French prospective cohort study of hospitalized COVID-19 patients. PLoS ONE, 2020, 15 (10), pp.e0240711. ⟨10.1371/journal.pone.0240711⟩. ⟨hal-03023169⟩
  • Cloé Comarmond, Mathilde Leclercq, Gaëlle Leroux, Cindy Marques, Alexandre Le Joncour, et al.. Correspondence on ‘Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: a monocentric survey’. Annals of the Rheumatic Diseases, 2020, pp.annrheumdis-2020-219407. ⟨10.1136/annrheumdis-2020-219407⟩. ⟨hal-03831033⟩
  • Vincent Langlois, André Gillibert, Yurdagül Uzunhan, Marie-Laure Chabi, Eric Hachulla, et al.. Rituximab and Cyclophosphamide in Antisynthetase Syndrome–related Interstitial Lung Disease: An Observational Retrospective Study. Journal of Rheumatology, 2020, 47 (11), pp.1678-1686. ⟨10.3899/jrheum.190505⟩. ⟨hal-03831037⟩
  • Elina Zuelgaray, Sylvie Chevret, Marie Jachiet, Patrice Cacoub, Jean-Emmanuel Kahn, et al.. Trunk involvement and peau d’orange aspect are poor prognostic factors in eosinophilic fasciitis (Shulman’s disease): a multicenter retrospective study of 119 patients. Journal of The American Academy of Dermatology, 2020, ⟨10.1016/j.jaad.2020.11.009⟩. ⟨hal-03831112⟩
  • Océane Landon-Cardinal, Damien Bachasson, Perrine Guillaume-Jugnot, Mathieu Vautier, Nicolas Champtiaux, et al.. Relationship between change in physical activity and in clinical status in patients with idiopathic inflammatory myopathy: A prospective cohort study. Seminars in Arthritis and Rheumatism, 2020, 50, pp.1140 - 1149. ⟨10.1016/j.semarthrit.2020.06.014⟩. ⟨hal-03491516⟩
  • Jules Russick, Pierre-Emmanuel Joubert, Mélanie Gillard-Bocquet, Carine Torset, Maxime Meylan, et al.. Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions. Journal for Immunotherapy of Cancer, 2020, 8 (2), pp.e001054. ⟨10.1136/jitc-2020-001054⟩. ⟨hal-03010006⟩
  • Benjamin Rossi, Lee Nguyen, Philippe Zimmermann, Faiza Boucenna, Louis Dubret, et al.. Effect of Tocilizumab in Hospitalized Patients with Severe COVID-19 Pneumonia: A Case-Control Cohort Study. Pharmaceuticals, 2020, 13 (10), pp.317. ⟨10.3390/ph13100317⟩. ⟨hal-03011642⟩
  • Olivier Benveniste, Yves Allenbach, Benjamin Granger. Response to: ‘On using machine learning algorithms to define clinically meaningful patient subgroups’ by Pinal-Fernandez and Mammen. Annals of the Rheumatic Diseases, 2020, 79 (10), pp.e130-e130. ⟨10.1136/annrheumdis-2019-216007⟩. ⟨hal-03523514⟩
  • Yves Allenbach, Céline Anquetil, Ali Manouchehri, Olivier Benveniste, Olivier Lambotte, et al.. Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities. Autoimmunity Reviews, 2020, 19 (8), pp.102586. ⟨10.1016/j.autrev.2020.102586⟩. ⟨hal-04003010v2⟩
  • Isabelle Melki, Hervé Devilliers, Cyril Gitiaux, Vincent Bondet, Darragh Duffy, et al.. Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signalling. Rheumatology, 2020, 59 (8), pp.1927-1937. ⟨10.1093/rheumatology/kez525⟩. ⟨pasteur-02383120⟩
  • Yves Allenbach, Yurdagul Uzunhan, Ségolène Toquet, Gaëlle Leroux, Laure Gallay, et al.. Different phenotypes in dermatomyositis associated with anti-MDA5 antibody. Neurology, 2020, 95 (1), pp.e70-e78. ⟨10.1212/WNL.0000000000009727⟩. ⟨hal-04713458⟩
  • Yves Allenbach, Yurdagul Uzunhan, Ségolène Toquet, Gaëlle Leroux, Laure Gallay, et al.. Different phenotypes in dermatomyositis associated with anti-MDA5 antibody. Neurology, 2020, 95 (1), pp.e70-e78. ⟨10.1212/WNL.0000000000009727⟩. ⟨hal-03425167⟩
  • Céline Anquetil, Joe-Elie Salem, Bénédicte Lebrun-Vignes, Sara Touhami, Anne-Claire Desbois, et al.. Evolving spectrum of drug-induced uveitis at the era of immune checkpoint inhibitors results from the WHO's pharmacovigilance database. Journal of Autoimmunity, 2020, 111, pp.102454. ⟨10.1016/j.jaut.2020.102454⟩. ⟨hal-02948973⟩
  • C. Jalles, A. Deroux, M. Tardieu, M. Lugosi, S. Viel, et al.. Dermatomyosite à anticorps anti-MDA5 sévère associée à un cancer et contrôlée par inhibiteur de JAK. La Revue de Médecine Interne, 2020, 41, pp.421 - 424. ⟨10.1016/j.revmed.2020.02.015⟩. ⟨hal-03490360⟩
  • Mathilde Duchesne, Sarah Leonard‐louis, Océane Landon‐cardinal, Céline Anquetil, Kuberaka Mariampillai, et al.. Edematous myositis: a clinical presentation first suggesting dermatomyositis diagnosis. Brain Pathology, 2020, bpa.12844. ⟨10.1111/bpa.12844⟩. ⟨hal-03523548⟩
  • Cort B Breuer, Killian S Hanlon, Jeya-Shree Natasan, Adrienn Volak, Amine Meliani, et al.. In vivo engineering of lymphocytes after systemic exosome-associated AAV delivery. Scientific Reports, 2020, 10 (1), pp.4544. ⟨10.1038/s41598-020-61518-w⟩. ⟨inserm-02511253⟩
  • Yannick Dieudonné, Yves Allenbach, Olivier Benveniste, Sarah Leonard-Louis, Baptiste Hervier, et al.. Granulomatosis-associated myositis. Neurology, 2020, 94 (9), pp.e910-e920. ⟨10.1212/WNL.0000000000008863⟩. ⟨hal-03523532⟩
  • Nadège Wesner, Akinori Uruha, Shigeaki Suzuki, Kubéraka Mariampillai, Benjamin Granger, et al.. Anti-RNP antibodies delineate a subgroup of myositis: A systematic retrospective study on 46 patients. Autoimmunity Reviews, 2020, 19, ⟨10.1016/j.autrev.2020.102465⟩. ⟨hal-03523398⟩
  • Ysoline Beigneux, Isabelle Arnulf, Perrine Guillaume-Jugnot, Smaranda Leu-Semenescu, Elisabeth Maillart, et al.. Secondary hypersomnia as an initial manifestation of neuromyelitis optica spectrum disorders. Multiple Sclerosis and Related Disorders, 2020, 38, pp.101869. ⟨10.1016/j.msard.2019.101869⟩. ⟨hal-03831010⟩
  • Berangere Bertin, Philippe Veron, Christian Leborgne, Jack-Yves Deschamps, Sophie Moullec, et al.. Capsid-specific removal of circulating antibodies to adeno-associated virus vectors. Scientific Reports, 2020, 10 (1), pp.864. ⟨10.1038/s41598-020-57893-z⟩. ⟨inserm-02489693⟩
  • Andrew Mammen, Yves Allenbach, Werner Stenzel, Olivier Benveniste, Jan De Bleecker, et al.. 239th ENMC International Workshop: Classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018. Neuromuscular Disorders, 2020, 30 (1), pp.70-92. ⟨10.1016/j.nmd.2019.10.005⟩. ⟨hal-03831090⟩
  • Nickie Seto, Jose Jiram Torres-Ruiz, Carmelo Carmona-Rivera, Iago Pinal-Fernandez, Katherine Pak, et al.. Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies. JCI Insight, 2020, 5 (3), pp.e134189. ⟨10.1172/jci.insight.134189⟩. ⟨hal-03831101⟩
  • Wladimir Mauhin, Olivier Benveniste, Damien Amelin, Clémence Montagner, Foudil Lamari, et al.. Cornea verticillata and acroparesthesia efficiently discriminate clusters of severity in Fabry disease. PLoS ONE, 2020, 15 (5), pp.e0233460. ⟨10.1371/journal.pone.0233460⟩. ⟨hal-02871577⟩
  • Jean-Yves Hogrel, Olivier Benveniste, Damien Bachasson. Routine monitoring of isometric knee extension strength in patients with muscle impairments using a new portable device: cross-validation against a standard isokinetic dynamometer. Physiological Measurement, 2020, 41 (1), pp.015003. ⟨10.1088/1361-6579/ab6b49⟩. ⟨hal-02530660⟩
  • Mrinmoy Das, Anupama Karnam, Emmanuel Stephen-Victor, Laurent Gilardin, Bharat Bhatt, et al.. Intravenous immunoglobulin mediates anti-inflammatory effects in peripheral blood mononuclear cells by inducing autophagy. Cell Death and Disease, 2020, 11 (1), pp.50. ⟨10.1038/s41419-020-2249-y⟩. ⟨inserm-02553444⟩
  • Abdellah Tebani, Wladimir Mauhin, Lénaïg Abily-Donval, Céline Lesueur, Marc Berger, et al.. A Proteomics-Based Analysis Reveals Predictive Biological Patterns in Fabry Disease. Journal of Clinical Medicine, 2020, 9 (5), pp.1325. ⟨10.3390/jcm9051325⟩. ⟨hal-02881962⟩
  • Wladimir Mauhin, Olivier Lidove, Olivier Benveniste. Of the importance of the clinical phenotypes in the interpretation of the studies dealing with Fabry disease. Orphanet Journal of Rare Diseases, 2019, 14 (1), pp.4. ⟨10.1186/s13023-018-0979-z⟩. ⟨hal-03523518⟩
  • Jérôme Poupiot, Helena Costa Verdera, Romain Hardet, Pasqualina Colella, Fanny Collaud, et al.. Role of Regulatory T Cell and Effector T Cell Exhaustion in Liver-Mediated Transgene Tolerance in Muscle. Molecular Therapy - Methods and Clinical Development, 2019, 15, pp.83 - 100. ⟨10.1016/j.omtm.2019.08.012⟩. ⟨hal-02392771⟩
  • Loïs Bolko, Cyril Gitiaux, Yves Allenbach. [Dermatomyositis: new antibody, new classification].. Médecine/Sciences, 2019, 35, pp.18-23. ⟨10.1051/medsci/2019178⟩. ⟨hal-03832528⟩
  • Olivier Benveniste, Yves Allenbach, Océane Landon-Cardinal. Reply: Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib. Brain - A Journal of Neurology , 2019, 142 (11), pp.e60-e60. ⟨10.1093/brain/awz294⟩. ⟨hal-03523494⟩
  • Perrine Guillaume-Jugnot, Sarah Guégan, Sarah Léonard-Louis, Stéphane Barete, Olivier Benveniste, et al.. Infliximab as effective treatment for aseptic neutrophilic myositis. Neurology, 2019, 93, pp.1009 - 1011. ⟨10.1212/wnl.0000000000008584⟩. ⟨hal-03523528⟩
  • Anne Simon, Anthony Behin, Tanya Stojkovic, Charles Duyckaerts, Guillaume Breton, et al.. Expanding the spectrum of HIV associated myopathy. Journal of Neurology, Neurosurgery and Psychiatry, 2019, 90 (11), pp.1296-1298. ⟨10.1136/jnnp-2018-319419⟩. ⟨hal-03523511⟩
  • Michael Hanna, Umesh Badrising, Olivier Benveniste, Thomas Lloyd, Merrilee Needham, et al.. Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial. The Lancet Neurology, 2019, 18 (9), pp.834-844. ⟨10.1016/S1474-4422(19)30200-5⟩. ⟨hal-03831123⟩
  • El Oussini, Olivier Benveniste, Yves Allenbach. Inclusion body myositis: accumulation of evidence for its autoimmune origin. Brain - A Journal of Neurology , 2019, 142 (9), pp.2549-2551. ⟨10.1093/brain/awz229⟩. ⟨hal-03523492⟩
  • Raquel Cabrera-Pérez, Ferran Vila-Julià, Michio Hirano, Federico Mingozzi, Javier Torres-Torronteras, et al.. Alpha-1-Antitrypsin Promoter Improves the Efficacy of an Adeno-Associated Virus Vector for the Treatment of Mitochondrial Neurogastrointestinal Encephalomyopathy. Human Gene Therapy, 2019, 30 (8), pp.985-998. ⟨10.1089/hum.2018.217⟩. ⟨hal-03877796⟩
  • Gaëlle Dzangué-Tchoupou, Yves Allenbach, Corinna Preusse, Werner Stenzel, Olivier Benveniste. Mass cytometry reveals an impairment of B cell homeostasis in anti-synthetase syndrome. Journal of Neuroimmunology, 2019, 332, pp.212 - 215. ⟨10.1016/j.jneuroim.2019.04.014⟩. ⟨hal-03477628⟩
  • Anke Rietveld, Johan Lim, Marianne de Visser, Baziel van Engelen, Ger Pruijn, et al.. Autoantibody testing in idiopathic inflammatory myopathies. Practical Neurology, 2019, 19 (4), pp.284-294. ⟨10.1136/practneurol-2017-001742⟩. ⟨hal-03831140⟩
  • Marc P Bonaca, Benjamin Olenchock, Joe-Elie Salem, Stephen Wiviott, Stephane Ederhy, et al.. Myocarditis in the Setting of Cancer Therapeutics. Circulation, 2019, 140 (1), pp.80-91. ⟨10.1161/CIRCULATIONAHA.118.034497⟩. ⟨hal-02373979⟩
  • Celine Anquetil, Eric Hachulla, Francois Machuron, Xavier Mariette, Pierre-Yves Hatron. Comment on: is early-onset primary sjögren''s syndrome a worse prognosis form of the disease? Reply. Rheumatology, 2019, Rheumatology, 58, pp.1312-1313. ⟨10.1093/rheumatology/kez074⟩. ⟨hal-04524820⟩
  • Audrey Aussy, Manuel Fréret, Laure Gallay, Didier Bessis, Thierry Vincent, et al.. The IgG2 Isotype of Anti–Transcription Intermediary Factor 1γ Autoantibodies Is a Biomarker of Cancer and Mortality in Adult Dermatomyositis. Arthritis & rheumatology, 2019, 71 (8), pp.1360-1370. ⟨10.1002/art.40895⟩. ⟨hal-02352134⟩
  • Douglas B Johnson, Joe-Elie Salem, Yves Allenbach, Aurore Vozy, Nicolas Brechot, et al.. Abatacept for Severe Immune Checkpoint Inhibitor–Associated Myocarditis. New England Journal of Medicine, 2019, 380 (24), pp.2377-2379. ⟨10.1056/NEJMc1901677⟩. ⟨hal-03155817⟩
  • Simon Rothwell, Hector Chinoy, Janine Lamb, Frederick Miller, Lisa Rider, et al.. Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups. Annals of the Rheumatic Diseases, 2019, 78 (7), pp.996-1002. ⟨10.1136/annrheumdis-2019-215046⟩. ⟨hal-03831144⟩
  • Océane Landon-Cardinal, Yves Allenbach, Antoine Soulages, Aude Rigolet, Baptiste Hervier, et al.. Rituximab in the Treatment of Refractory Anti-HMGCR Immune-mediated Necrotizing Myopathy. Journal of Rheumatology, 2019, 46 (6), pp.623-627. ⟨10.3899/jrheum.171495⟩. ⟨hal-03523536⟩
  • Samuel Knauss, Corinna Preusse, Yves Allenbach, Sarah Leonard-Louis, Mehdi Touat, et al.. PD1 pathway in immune-mediated myopathies. Neurology Neuroimmunology & Neuroinflammation, 2019, 6 (3), pp.e558. ⟨10.1212/NXI.0000000000000558⟩. ⟨hal-03831126⟩
  • Yves Allenbach, Kubéraka Mariampillai, Olivier Benveniste. Autoantibodies at the Center of (sub)Classification—Issues of Detection—Reply. JAMA neurology, 2019, 76 (7), pp.868. ⟨10.1001/jamaneurol.2019.0443⟩. ⟨hal-03523452⟩
  • Gaëlle Dzangué-Tchoupou, Kuberaka Mariampillai, Loïs Bolko, Damien Amelin, Wladimir Mauhin, et al.. CD8+T-bet+ cells as a predominant biomarker for inclusion body myositis. Autoimmunity Reviews, 2019, 18 (4), pp.325-333. ⟨10.1016/j.autrev.2019.02.003⟩. ⟨hal-02534985⟩
  • Lee Nguyen, Mathieu Vautier, Yves Allenbach, Noel Zahr, Olivier Benveniste, et al.. Sirolimus and mTOR Inhibitors: A Review of Side Effects and Specific Management in Solid Organ Transplantation. Drug Safety, 2019, ⟨10.1007/s40264-019-00810-9⟩. ⟨hal-02136137⟩
  • Adrian Huber, Jérôme Lamy, Marine Bravetti, Khaoula Bouazizi, Tania Bacoyannis, et al.. Comparison of MR T1 and T2 mapping parameters to characterize myocardial and skeletal muscle involvement in systemic idiopathic inflammatory myopathy (IIM). European Radiology, 2019, ⟨10.1007/s00330-019-06054-6⟩. ⟨hal-02150194⟩
  • Jan Damoiseaux, Jean-Baptiste Vulsteke, Chih-Wei Tseng, Anouk Platteel, Yves Piette, et al.. Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays. Autoimmunity Reviews, 2019, 18 (3), pp.293-305. ⟨10.1016/j.autrev.2018.10.004⟩. ⟨hal-03832539⟩
  • Fanny Collaud, Giulia Bortolussi, Laurence Guianvarc'H, Sem Aronson, Thierry Bordet, et al.. Preclinical Development of an AAV8-hUGT1A1 Vector for the Treatment of Crigler-Najjar Syndrome. Molecular Therapy - Methods and Clinical Development, 2019, 12, pp.157-174. ⟨10.1016/j.omtm.2018.12.011⟩. ⟨hal-02179298⟩
  • Céline Anquetil, Olivier Boyer, Nadège Wesner, Olivier Benveniste, Yves Allenbach. Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy. Autoimmunity Reviews, 2019, 18 (3), pp.223-230. ⟨10.1016/j.autrev.2018.09.008⟩. ⟨hal-02377517⟩
  • B. Bader-Meunier, C. Gitiaux, A. Belot, K. Brochard, R. Mouy, et al.. French expert opinion for the management of juvenile dermatomyositis. Archives de Pédiatrie, 2019, 26 (2), pp.120-125. ⟨10.1016/j.arcped.2018.12.002⟩. ⟨hal-03523461⟩
  • Océane Landon-Cardinal, Hervé Devilliers, Nathalie Chavarot, Kuberaka Mariampillai, Aude Rigolet, et al.. Responsiveness to Change of 5-point MRC scale, Endurance and Functional Evaluation for Assessing Myositis in Daily Clinical Practice. Journal of Neuromuscular Diseases, 2019, 6 (1), pp.99-107. ⟨10.3233/JND-180358⟩. ⟨hal-03523534⟩
  • Norina Fischer, Corinna Preusse, Josefine Radke, Debora Pehl, Yves Allenbach, et al.. Sequestosome‐1 (p62) expression reveals chaperone‐assisted selective autophagy in immune‐mediated necrotizing myopathies. Brain Pathology, In press, ⟨10.1111/bpa.12772⟩. ⟨hal-02285393⟩
  • Olivier Benveniste, Hans-Hilmar Goebel, Werner Stenzel. Biomarkers in Inflammatory Myopathies—An Expanded Definition. Frontiers in Neurology, 2019, 10, pp.554. ⟨10.3389/fneur.2019.00554⟩. ⟨hal-03831117⟩
  • Pascal Laforêt, Michio Inoue, Evelyne Goillot, Claire Lefeuvre, Umut Cagin, et al.. Deep morphological analysis of muscle biopsies from type III glycogenesis (GSDIII), debranching enzyme deficiency, revealed stereotyped vacuolar myopathy and autophagy impairment. Acta Neuropathologica Communications, 2019, 7 (1), ⟨10.1186/s40478-019-0815-2⟩. ⟨hal-02414161⟩
  • Yves Allenbach, Lois Bolko, Olivier Benveniste, Ségolène Toquet, Océane Landon-Cardinal. Reply: Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis. Brain - A Journal of Neurology , 2019, 142 (3), pp.e9-e9. ⟨10.1093/brain/awz006⟩. ⟨hal-03523485⟩
  • Timothée Lenglet, Jonathan Mirault, Marie Veyrat-Masson, Aurélie Funkiewiez, Maria del Mar Amador, et al.. Cursive Eye-Writing With Smooth-Pursuit Eye-Movement Is Possible in Subjects With Amyotrophic Lateral Sclerosis. Frontiers in Neuroscience, 2019, 13, pp.538. ⟨10.3389/fnins.2019.00538⟩. ⟨hal-02172322⟩
  • Caroline C Galeotti, Emmanuel Stephen-Victor, Anupama Karnam, Mrinmoy Das, Laurent Gilardin, et al.. Intravenous immunoglobulin induces IL-4 in human basophils by signaling through 1 surface-bound IgE. Journal of Allergy and Clinical Immunology, 2019, 144 (2), pp.524-535.e8. ⟨10.1016/j.jaci.2018.10.064⟩. ⟨hal-02284256⟩
  • Johanna Palmio, Sarah Léonard-Louis, Sabrina Sacconi, Marco Savarese, Sini Penttilä, et al.. Expanding the importance of HMERF titinopathy: new mutations and clinical aspects. Journal of Neurology, 2019, 266 (3), pp.680-690. ⟨10.1007/s00415-019-09187-2⟩. ⟨hal-02064991⟩
  • Cecile Bergua, Hélène Chiavelli, Yves Allenbach, Louiza Arouche-Delaperche, Christophe Arnoult, et al.. In vivo pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy. Annals of the Rheumatic Diseases, 2018, 78 (1), pp.131-139. ⟨10.1136/annrheumdis-2018-213518⟩. ⟨hal-02366089⟩
  • Céline Anquetil, Eric Hachulla, François Machuron, Xavier Mariette, Veronique Le Guern, et al.. Is early-onset primary Sjögren’s syndrome a worse prognosis form of the disease?. Rheumatology, 2018, ⟨10.1093/rheumatology/key392⟩. ⟨hal-01965657⟩
  • Florence Boisgérault, Amine Meliani, Romain Hardet, Solenne Marmier, Fanny Collaud, et al.. Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration. Nature Communications, 2018, 9 (1), pp.4098. ⟨10.1038/s41467-018-06621-3⟩. ⟨hal-02177709⟩
  • S. Toquet, Y. Uzunhan, G. Leroux, B. Bonnotte, L. Gallay, et al.. Facteurs pronostiques de la dermatomyosite à anticorps anti-MDA5 : sexe féminin et atteinte articulaire de bon pronostic. La Revue de Médecine Interne, 2018, 39 (1), pp.A114. ⟨10.1016/j.revmed.2018.03.364⟩. ⟨hal-03833997⟩
  • Kubéraka Mariampillai, Benjamin Granger, Damien Amelin, Marguerite Guiguet, Eric Hachulla, et al.. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies. JAMA neurology, 2018, 75 (12), pp.1528-1537. ⟨10.1001/jamaneurol.2018.2598⟩. ⟨hal-03831196⟩
  • Payam Mohassel, Océane Landon-Cardinal, A. Reghan Foley, Sandra Donkervoort, Katherine Pak, et al.. Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy. Neurology Neuroimmunology & Neuroinflammation, 2018, 6, pp.e523. ⟨10.1212/NXI.0000000000000523⟩. ⟨hal-03831137⟩
  • Akinori Uruha, Yves Allenbach, J-L Charuel, Lucile Musset, Audrey Aussy, et al.. Diagnostic potential of sarcoplasmic myxovirus resistance protein A expression in subsets of dermatomyositis. Neuropathology and Applied Neurobiology, 2018, 45, pp.513 - 522. ⟨10.1111/nan.12519⟩. ⟨hal-03523507⟩
  • Pasqualina Colella, Pauline Sellier, Helena Costa Verdera, Francesco Puzzo, Laetitia van Wittenberghe, et al.. AAV Gene Transfer with Tandem Promoter Design Prevents Anti-transgene Immunity and Provides Persistent Efficacy in Neonate Pompe Mice. Molecular Therapy - Methods and Clinical Development, 2018, 12, pp.85-101. ⟨10.1016/j.omtm.2018.11.002⟩. ⟨hal-02087558⟩
  • Yves Allenbach, Ségolène Toquet, Océane Landon-Cardinal, Olivier Benveniste. Reply: A child with severe juvenile dermatomyositis treated with ruxolitinib. Brain - A Journal of Neurology , 2018, 141 (11), pp.e81-e81. ⟨10.1093/brain/awy256⟩. ⟨hal-03831155⟩
  • Klaudia Kuranda, Priscilla Jean-Alphonse, Christian Leborgne, Romain Hardet, Fanny Collaud, et al.. Exposure to wild-type AAV drives distinct capsid immunity profiles in humans. Journal of Clinical Investigation, 2018, 128 (12), pp.5267-5279. ⟨10.1172/JCI122372⟩. ⟨hal-01977027⟩
  • Océane Landon-Cardinal, François Prince, Stéphane Bédard, Olivier Benveniste, Marie Hudson. Dermoskeletics to preserve mobility and function in inclusion body myositis. Neurology, 2018, 91 (16), pp.760-760. ⟨10.1212/WNL.0000000000006365⟩. ⟨hal-03831176⟩
  • Mehdi Touat, Thierry Maisonobe, Samuel Knauss, Omar Ben Hadj Salem, Baptiste Hervier, et al.. Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer. Neurology, 2018, 91 (10), pp.e985-e994. ⟨10.1212/WNL.0000000000006124⟩. ⟨hal-03831205⟩
  • Roberta Lorenzon, Encarnita Mariotti-Ferrandiz, Caroline Aheng, Claire Ribet, Férial Toumi, et al.. Clinical and multi-omics cross-phenotyping of patients with autoimmune and autoinflammatory diseases: the observational TRANSIMMUNOM protocol. BMJ Open, 2018, 8 (8), pp.e021037. ⟨10.1136/bmjopen-2017-021037⟩. ⟨inserm-01978798⟩
  • Céline Anquetil, Joe-Elie Salem, Bénédicte Lebrun-Vignes, Douglas Johnson, Andrew Mammen, et al.. Immune Checkpoint Inhibitor–Associated Myositis. Circulation, 2018, 138 (7), pp.743-745. ⟨10.1161/CIRCULATIONAHA.118.035898⟩. ⟨hal-03831164⟩
  • Roberta Lorenzon, Encarnita Mariotti-Ferrandiz, Caroline Aheng, Claire Ribet, Ferial Toumi, et al.. Clinical and multi-omics cross-phenotyping of patients with autoimmune and autoinflammatory diseases: the observational TRANSIMMUNOM protocol. BMJ Open, 2018, 8 (8), pp.e021037. ⟨10.1136/bmjopen-2017-021037⟩. ⟨hal-04000044⟩
  • G. Bourdenet, B. Dubourg, L. Nicol, P. Mulder, J. Martinet, et al.. Value of magnetic resonance imaging for evaluating muscle inflammation: insights from a new mouse model of myositis. Neuropathology and Applied Neurobiology, 2018, 44 (5), pp.537-540. ⟨10.1111/nan.12457⟩. ⟨hal-02430388⟩
  • Damien Bachasson, Guillaume J.R. Dubois, Yves Allenbach, Olivier Benveniste, Jean-Yves Hogrel. Muscle Shear Wave Elastography in Inclusion Body Myositis: Feasibility, Reliability and Relationships with Muscle Impairments. Ultrasound in Medicine & Biology, 2018, 44 (7), pp.1423-1432. ⟨10.1016/j.ultrasmedbio.2018.03.026⟩. ⟨hal-01961259⟩
  • Joanna Parkes, Simon Rothwell, Alexander Oldroyd, Hector Chinoy, Janine Lamb, et al.. Genetic background may contribute to the latitude-dependent prevalence of dermatomyositis and anti-TIF1-γ autoantibodies in adult patients with myositis. Arthritis Research & Therapy, 2018, 20 (1), pp.117. ⟨10.1186/s13075-018-1617-9⟩. ⟨hal-03831199⟩
  • Leandro Ladislau, Xavier Suárez-Calvet, Ségolène Toquet, Océane Landon-Cardinal, Damien Amelin, et al.. JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis. Brain - A Journal of Neurology , 2018, 141 (6), pp.1609 - 1621. ⟨10.1093/brain/awy105⟩. ⟨pasteur-01819244⟩
  • Océane Landon-Cardinal, Diane Friedman, Marguerite Guiguet, Pascal Laforet, Nicholas Heming, et al.. Efficacy of Rituximab in Refractory Generalized anti-AChR Myasthenia Gravis. Journal of Neuromuscular Diseases, 2018, 5 (2), pp.241-249. ⟨10.3233/JND-180300⟩. ⟨hal-02377514⟩
  • Leandro Ladislau, Débora M. Portilho, Tristan Courau, Alhondra Solares-Pérez, Elisa Negroni, et al.. Activated dendritic cells modulate proliferation and differentiation of human myoblasts. Cell Death and Disease, 2018, 9 (5), pp.551. ⟨10.1038/s41419-018-0426-z⟩. ⟨hal-03273530v2⟩
  • Gaëlle Dzangué-Tchoupou, Aurélien Corneau, Catherine Blanc, Olivier Benveniste, Yves Allenbach. Analysis of cell surface and intranuclear markers on non-stimulated human PBMC using mass cytometry. PLoS ONE, 2018, 13 (3), pp.e0194593. ⟨10.1371/journal.pone.0194593⟩. ⟨hal-01774882⟩
  • Patrice Vidal, Serena Pagliarani, Pasqualina Colella, Helena Costa Verdera, Louisa Jauze, et al.. Rescue of GSDIII Phenotype with Gene Transfer Requires Liver- and Muscle-Targeted GDE Expression. Molecular Therapy, 2018, 26 (3), pp.890-901. ⟨10.1016/j.ymthe.2017.12.019⟩. ⟨hal-02332988⟩
  • Fleur Cohen Aubart, Salam Abbara, Thierry Maisonobe, Vincent Cottin, Thomas Papo, et al.. Symptomatic muscular sarcoidosis. Neurology Neuroimmunology & Neuroinflammation, 2018, 5 (3), pp.e452. ⟨10.1212/NXI.0000000000000452⟩. ⟨hal-03831168⟩
  • Christian Leborgne, Virginie Latournerie, Sylvie Boutin, Diana Desgue, Aliénor Quéré, et al.. Prevalence and long-term monitoring of humoral immunity against adeno-associated virus in Duchenne Muscular Dystrophy patients. Cellular Immunology, 2018, pp.103780. ⟨10.1016/j.cellimm.2018.03.004⟩. ⟨hal-02179236⟩
  • Josefine Radke, Randi Koll, Corinna Preuße, Debora Pehl, Kremena Todorova, et al.. Architectural B-cell organization in skeletal muscle identifies subtypes of dermatomyositis. Neurology Neuroimmunology & Neuroinflammation, 2018, 5 (3), pp.e451. ⟨10.1212/NXI.0000000000000451⟩. ⟨hal-03831202⟩
  • Adrian T. Huber, Marine Bravetti, Jérôme Lamy, Tania Bacoyannis, Charles Roux, et al.. Non-invasive differentiation of idiopathic inflammatory myopathy with cardiac involvement from acute viral myocarditis using cardiovascular magnetic resonance imaging T1 and T2 mapping. Journal of Cardiovascular Magnetic Resonance, 2018, 20 (1), pp.11. ⟨10.1186/s12968-018-0430-6⟩. ⟨inserm-01711470⟩
  • Yves Allenbach, Louiza Arouche-Delaperche, Corinna Preusse, Helena Radbruch, Gillian Butler-Browne, et al.. Necrosis in anti-SRP + and anti-HMGCR + myopathies. Neurology, 2018, 90 (6), pp.e507-e517. ⟨10.1212/WNL.0000000000004923⟩. ⟨hal-02377509⟩
  • Wladimir Mauhin, Olivier Lidove, Damien Amelin, Foudil Lamari, Catherine Caillaud, et al.. Deep characterization of the anti-drug antibodies developed in Fabry disease patients, a prospective analysis from the French multicenter cohort FFABRY. Orphanet Journal of Rare Diseases, 2018, 13 (1), pp.127. ⟨10.1186/s13023-018-0877-4⟩. ⟨hal-02086919⟩
  • Yves Allenbach, Andrew Mammen, Olivier Benveniste, Werner Stenzel, Anthony Amato, et al.. 224th ENMC International Workshop: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016.. Neuromuscular Disorders, 2018, 28 (1), pp.87-99. ⟨10.1016/j.nmd.2017.09.016⟩. ⟨hal-03831153⟩
  • Pasqualina Colella, Giuseppe Ronzitti, Federico Mingozzi. Emerging Issues in AAV-Mediated In Vivo Gene Therapy. Molecular Therapy - Methods and Clinical Development, 2018, 8, pp.87-104. ⟨10.1016/j.omtm.2017.11.007⟩. ⟨hal-01812088⟩
  • Zachary Fitzpatrick, Christian Leborgne, Elena Barbon, Elisa Masat, Giuseppe Ronzitti, et al.. Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction. Molecular Therapy - Methods and Clinical Development, 2018, 9, pp.119-129. ⟨10.1016/j.omtm.2018.02.003⟩. ⟨hal-01830017⟩
  • Yves Allenbach, Olivier Benveniste. Peculiar clinicopathological features of immune-mediated necrotizing myopathies. Current Opinion in Rheumatology, 2018, 30 (6), pp.655-663. ⟨10.1097/BOR.0000000000000547⟩. ⟨hal-03523499⟩
  • I. Donadon, M. Pinotti, K. Rajkowska, G. Pianigiani, E. Barbon, et al.. Exon-specific U1 snRNAs improve ELP1 exon 20 definition and rescue ELP1 protein expression in a familial dysautonomia mouse model. Hum Mol Genet, 2018, 27, pp.2466-2476. ⟨10.1093/hmg/ddy151⟩. ⟨hal-02880794⟩
  • Guillaume J.R. Dubois, Damien Bachasson, Lilian Lacourpaille, Olivier Benveniste, Jean-Yves Hogrel. Local Texture Anisotropy as an Estimate of Muscle Quality in Ultrasound Imaging. Ultrasound in Medicine & Biology, 2018, 44 (5), pp.1133-1140. ⟨10.1016/j.ultrasmedbio.2017.12.017⟩. ⟨hal-01962400⟩
  • James Lilleker, Jiri Vencovsky, Guochun Wang, Lucy Wedderburn, Louise Diederichsen, et al.. Response to: ‘Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria’ by Cavagna et al. Annals of the Rheumatic Diseases, 2017, pp.annrheumdis-2017-212382. ⟨10.1136/annrheumdis-2017-212382⟩. ⟨hal-03831184⟩
  • James Lilleker, Jiri Vencovsky, Guochun Wang, Lucy Wedderburn, Louise Pyndt Diederichsen, et al.. The EuroMyositis registry: an international collaborative tool to facilitate myositis research. Annals of the Rheumatic Diseases, 2017, 77 (1), pp.30-39. ⟨10.1136/annrheumdis-2017-211868⟩. ⟨hal-03831192⟩
  • Laureline Berthelot, Agnès Jamin, Denis Viglietti, Jonathan Maurice M Chemouny, Hamza Ayari, et al.. Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort. Nephrology Dialysis Transplantation, 2017, ⟨10.1093/ndt/gfx300⟩. ⟨hal-02445650⟩
  • Xavier Puechal, Christian Pagnoux, Gabriel Baron, Thomas Quemeneur, Antoine Néel, et al.. Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors. Arthritis & rheumatology, 2017, 69 (11), pp.2175 - 2186. ⟨10.1002/art.40205⟩. ⟨hal-01656761⟩
  • Céline Vandamme, Oumeya Adjali, Federico Mingozzi. Unraveling the Complex Story of Immune Responses to AAV Vectors Trial After Trial. Human Gene Therapy, 2017, 28 (11), pp.1061 - 1074. ⟨10.1089/hum.2017.150⟩. ⟨inserm-01798967⟩
  • Amine Meliani, Florence Boisgérault, Zachary Fitzpatrick, Solenne Marmier, Christian Leborgne, et al.. Enhanced liver gene transfer and evasion of preexisting humoral immunity with exosome-enveloped AAV vectors. Blood Advances, 2017, 1 (23), pp.2019-2031. ⟨10.1182/bloodadvances.2017010181⟩. ⟨hal-02377508⟩
  • Alain Meyer, Gilles Laverny, Yves Allenbach, Elise Grelet, Vanessa Ueberschlag, et al.. IFN-β-induced reactive oxygen species and mitochondrial damage contribute to muscle impairment and inflammation maintenance in dermatomyositis. Acta Neuropathologica, 2017, 134 (4), pp.655-666. ⟨10.1007/s00401-017-1731-9⟩. ⟨hal-02377506⟩
  • Marc Pineton de Chambrun, Marie Gousseff, Wladimir Mauhin, Jean-Christophe Lega, Marc Lambert, et al.. Intravenous Immunoglobulins Improve Survival in Monoclonal Gammopathy-Associated Systemic Capillary-Leak Syndrome. The American Journal of Medicine, 2017, 130 (10), pp.1219.e19 - 1219.e27. ⟨10.1016/j.amjmed.2017.05.023⟩. ⟨hal-01656768⟩
  • C. Ambonville, M.-A. Bouldouyre, P. Laforêt, P. Richard, Olivier Benveniste, et al.. Un diabète particulièrement compliqué. La Revue de Médecine Interne, 2017, 38 (10), pp.695-699. ⟨10.1016/j.revmed.2017.04.006⟩. ⟨hal-03831215⟩
  • V. Mariot, R. Joubert, C. Hourdé, L. Féasson, M. Hanna, et al.. Reversible endogenous downregulation of myostatin pathway in wasting neuromuscular diseases explains challenges of anti-myostatin therapeutic approaches. Neuromuscular Disorders, 2017, 27, pp.S97-S98. ⟨10.1016/J.NMD.2017.06.026⟩. ⟨hal-03158871⟩
  • V. Mariot, R. Joubert, C. Hourdé, L. Féasson, M. Hanna, et al.. Myostatin expression levels in neuromuscular diseases participates in anti-myostatin clinical failure. Neuromuscular Disorders, 2017, 27, pp.S231. ⟨10.1016/J.NMD.2017.06.490⟩. ⟨hal-03158311⟩
  • F. Mingozzi, K. A. High. Overcoming the Host Immune Response to Adeno-Associated Virus Gene Delivery Vectors: The Race Between Clearance, Tolerance, Neutralization, and Escape. Annual Review of Virology, 2017, 4 (1), pp.511-534. ⟨10.1146/annurev-virology-101416-041936⟩. ⟨hal-02881005⟩
  • Damien Bachasson, Océane Landon-Cardinal, Olivier Benveniste, Jean-Yves Hogrel, Yves Allenbach. Physical activity monitoring: A promising outcome measure in idiopathic inflammatory myopathies. Neurology, 2017, 89 (1), pp.101-103. ⟨10.1212/WNL.0000000000004061⟩. ⟨hal-03831217⟩
  • M. Hosel, A. Huber, S. Bohlen, J. Lucifora, G. Ronzitti, et al.. Autophagy determines efficiency of liver-directed gene therapy with adeno-associated viral vectors. Hepatology, 2017, 66 (1), pp.252-265. ⟨10.1002/hep.29176⟩. ⟨hal-02880988⟩
  • Damien Bachasson, Océane Landon-Cardinal, Olivier Benveniste, Jean-Yves Hogrel, Yves Allenbach. Physical activity monitoring: A promising outcome measure in idiopathic inflammatory myopathies. Neurology, 2017, 89 (1), pp.101-103. ⟨10.1212/wnl.0000000000004061⟩. ⟨hal-04554731⟩
  • Simon Rothwell, Robert Cooper, Ingrid Lundberg, Peter Gregersen, Michael Hanna, et al.. Immune‐Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA–DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum. Arthritis & rheumatology, 2017, 69 (5), pp.1090-1099. ⟨10.1002/art.40045⟩. ⟨hal-03831238⟩
  • Rohit Aggarwal, Lisa Rider, Nicolino Ruperto, Nastaran Bayat, Brian Erman, et al.. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Arthritis & rheumatology, 2017, 69 (5), pp.898-910. ⟨10.1002/art.40064⟩. ⟨hal-03831209⟩
  • J Lilleker, A Rietveld, S Pye, K Mariampillai, Olivier Benveniste, et al.. Cytosolic 5′-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis. Annals of the Rheumatic Diseases, 2017, 76 (5), pp.862-868. ⟨10.1136/annrheumdis-2016-210282⟩. ⟨hal-03831234⟩
  • Nicolas Belhomme, Adel Maamar, Thomas Le Gallou, Marie-Christine Minot-Myhié, Antoine Larralde, et al.. Rare myopathy associated to MGUS, causing heart failure and responding to chemotherapy. Annals of Hematology, 2017, 96 (4), pp.695-696. ⟨10.1007/s00277-016-2916-3⟩. ⟨hal-01558317⟩
  • David Mack, Karine Poulard, Melissa Goddard, Virginie Latournerie, Jessica Snyder, et al.. Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs. Molecular Therapy, 2017, 25 (4), pp.839-854. ⟨10.1016/j.ymthe.2017.02.004⟩. ⟨hal-02179363⟩
  • Louiza Arouche-Delaperche, Yves Allenbach, Damien Amelin, Corinna Preusse, Vincent Mouly, et al.. Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies. Annals of Neurology, 2017, 81 (4), pp.538-548. ⟨10.1002/ana.24902⟩. ⟨hal-02377502⟩
  • Vadim Afanasiev, Sophie Demeret, Francis Bolgert, Bruno Eymard, Pascal Laforêt, et al.. Resistant myasthenia gravis and rituximab: A monocentric retrospective study of 28 patients. Neuromuscular Disorders, 2017, 27 (3), pp.251-258. ⟨10.1016/j.nmd.2016.12.004⟩. ⟨hal-03831207⟩
  • R. Hardet, F. Mingozzi. Oral Tolerance: Another Reason to Eat Your Veggies!. Molecular Therapy, 2017, 25 (2), pp.311-313. ⟨10.1016/j.ymthe.2017.01.001⟩. ⟨hal-02880984⟩
  • Y. Allenbach, Olivier Benveniste, H-H. Goebel, W. Stenzel. Integrated classification of inflammatory myopathies. Neuropathology and Applied Neurobiology, 2017, 43 (1), pp.62-81. ⟨10.1111/nan.12380⟩. ⟨hal-03831213⟩
  • Akinori Uruha, Olivier Benveniste. Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance. Current Opinion in Neurology, 2017, 30 (5), pp.457 - 463. ⟨10.1097/WCO.0000000000000477⟩. ⟨hal-01684027⟩
  • Wladimir Mauhin, Kuberaka Mariampillai, Yves Allenbach, Jean-Luc Charuel, Lucile Musset, et al.. Anti-mitochondrial antibodies are not a hallmark of severity in idiopathic inflammatory myopathies. Joint Bone Spine, 2017, ⟨10.1016/j.jbspin.2017.04.004⟩. ⟨hal-01518320⟩
  • Margaret M. Mcgovern, Ruzan Avetisyan, Bernd-Jan Sanson, Olivier Lidove. Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD). Orphanet Journal of Rare Diseases, 2017, 12, pp.41. ⟨10.1186/s13023-017-0572-x⟩. ⟨hal-01480359⟩
  • Marc Ruivard, Marc Pineton de Chambrun, Charles-Edouard Luyt, Francois Beloncle, Marie Gousseff, et al.. The Clinical Picture of Severe Systemic Capillary-Leak Syndrome Episodes Requiring ICU Admission. Critical Care Medicine, 2017, 45 (7), pp.1216 - 1223. ⟨10.1097/CCM.0000000000002496⟩. ⟨hal-01656772⟩
  • L. Gallay, N. Streichenberger, O. Benveniste, Y. Allenbach. Myosite focale : une maladie méconnue. La Revue de Médecine Interne, 2017, 38 (10), pp.679-684. ⟨10.1016/j.revmed.2017.06.015⟩. ⟨hal-01676079⟩
  • Lucile Musset, Yves Allenbach, Olivier Benveniste, Olivier Boyer, Xavier Bossuyt, et al.. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study. Autoimmunity Reviews, 2016, 15 (10), pp.983-993. ⟨10.1016/j.autrev.2016.07.023⟩. ⟨hal-02377492⟩
  • Yves Allenbach, Jeremy Keraen, Anne-Marie Bouvier, Valérie Jooste, Nicolas Champtiaux, et al.. High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody. Brain - A Journal of Neurology , 2016, 139 (8), pp.2131 - 2135. ⟨10.1093/brain/aww054⟩. ⟨hal-01409979⟩
  • E. Hachulla, Olivier Benveniste, M. Hamidou, L. Mouthon, N. Schleinitz, et al.. High dose subcutaneous immunoglobulin for idiopathic inflammatory myopathies and dysimmune peripheral chronic neuropathies treatment: observational study of quality of life and tolerance. International Journal of Neuroscience, 2016, 127 (6), pp.516-523. ⟨10.1080/00207454.2016.1204544⟩. ⟨hal-03831224⟩
  • Sébastien Sanges, Cécile M Yelnik, Olivier Sitbon, Olivier Benveniste, Kuberaka Mariampillai, et al.. Pulmonary arterial hypertension in idiopathic inflammatory myopathies. Medicine, 2016, 95 (39), pp.e4911. ⟨10.1097/MD.0000000000004911⟩. ⟨hal-01963451⟩
  • Elisa Masat, Pascal Laforêt, Marie de Antonio, Guillaume Corre, Barbara Perniconi, et al.. Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in late-onset Pompe disease patients. Scientific Reports, 2016, 6, pp.36182. ⟨10.1038/srep36182⟩. ⟨hal-01404918⟩
  • Fernanda Pinto-Mariz, Luciana Rodrigues Carvalho, Alexandra Prufer de Queiroz Campos Araujo, Wallace de Mello, Márcia Gonçalves Ribeiro, et al.. CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy. Skeletal Muscle, 2015, 5 (45), pp.1-10. ⟨10.1186/s13395-015-0066-2⟩. ⟨hal-01241371⟩
  • Yves Allenbach, Marguerite Guiguet, Aude Rigolet, Isabelle Marie, Eric Hachulla, et al.. Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial. PLoS ONE, 2015, 10 (11), pp.e0133702. ⟨10.1371/journal.pone.0133702⟩. ⟨hal-01277958⟩
  • Manuelle Viguier, Stéphanie Rist, François Aubin, Marie-Thérèse Leccia, Marie-Aleth Richard, et al.. Online Training on Skin Cancer Diagnosis in Rheumatologists: Results from a Nationwide Randomized Web-Based Survey. PLoS ONE, 2015, ⟨10.1371/journal.pone.0127564⟩. ⟨hal-01211398⟩
  • Alain Meyer, Guillaume Lefevre, Guillaume Bierry, Aurélie Duval, Sébastien Ottaviani, et al.. In Antisynthetase Syndrome, ACPA Are Associated With Severe and Erosive Arthritis: An Overlapping Rheumatoid Arthritis and Antisynthetase Syndrome. Medicine, 2015, 94 (20), pp.e523. ⟨10.1097/MD.0000000000000523⟩. ⟨hal-01226438⟩
  • Olivier Benveniste, Werner Stenzel, David Hilton-Jones, Marco Sandri, Olivier Boyer, et al.. Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken. Acta Neuropathologica, 2015, 129 (5), pp.611-624. ⟨10.1007/s00401-015-1384-5⟩. ⟨hal-02377450⟩
  • Guillaume Lefèvre, Alain Meyer, David Launay, Irène Machelart, Michel Debandt, et al.. Seronegative polyarthritis revealing antisynthetase syndrome: a multicentre study of 40 patients. Rheumatology, 2015, 54 (5), pp.927-932. ⟨10.1093/rheumatology/keu404⟩. ⟨hal-02416117⟩
  • Maeva Ferrari, Karine Louati, Anne Miquel, Anthony Behin, Olivier Benveniste, et al.. Quickly progressive amyotrophy of the thigh: An unusual cause of rapid chondrolysis of the knee. Joint Bone Spine, 2015, 82 (3), pp.203-205. ⟨10.1016/j.jbspin.2014.12.013⟩. ⟨hal-01117107⟩
  • Yves Allenbach, Wahiba Chaara, Michelle Rosenzwajg, Adrien Six, Nicolas Prevel, et al.. Th1 Response and Systemic Treg Deficiency in Inclusion Body Myositis. PLoS ONE, 2014, 9 (3), pp.e88788. ⟨10.1371/journal.pone.0088788⟩. ⟨hal-01344508⟩
  • Laurent Drouot, Yves Allenbach, Fabienne Jouen, Jean-Luc Charuel, Jérémie Martinet, et al.. Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies.. Arthritis Research and Therapy, 2014, 16 (1), pp.R39. ⟨10.1186/ar4468⟩. ⟨inserm-00950634⟩
  • G. Couvrat-Desvergnes, A. Masseau, O. Benveniste, A. Bruel, B. Hervier, et al.. The spectrum of renal involvement in patients with inflammatory myopathies. Medicine (Baltimore), 2014, 93 (1), pp.33-41. ⟨10.1097/MD.0000000000000015⟩. ⟨hal-01859438⟩
  • Meenu Sharma, Yoland Schoindre, Pushpa Hegde, Chaitrali Saha, Mohan S Maddur, et al.. Intravenous immunoglobulin-induced IL-33 is insufficient to mediate basophil expansion in autoimmune patients. Scientific Reports, 2014, 4 (1), pp.5672. ⟨10.1038/srep05672⟩. ⟨hal-01358914⟩
  • Marion Desdouits, Olivier Cassar, Thierry Maisonobe, Alexandra Desrames, Achille Aouba, et al.. HTLV-1-associated inflammatory myopathies: low proviral load and moderate inflammation in 13 patients from West Indies and West Africa.. Journal of Clinical Virology, 2013, 57 (1), pp.70-6. ⟨10.1016/j.jcv.2012.12.016⟩. ⟨pasteur-01370950⟩
  • France Herson, Faycal Hentati, Aude Rigolet, Anthony Behin, Norma Beatriz Romero, et al.. A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C. Brain - A Journal of Neurology , 2012, 135 (2), pp.483-492. ⟨10.1093/brain/awr342⟩. ⟨hal-02179399⟩
  • V. Monteilhet, S. Saheb, Sylvie Boutin, C. Leborgne, P. Veron, et al.. A 10 patient case report on the impact of plasmapheresis upon neutralizing factors against adeno-associated virus (AAV) types 1, 2, 6, and 8. Molecular Therapy, 2011, 19 (11), pp.2084-91. ⟨10.1038/mt.2011.108⟩. ⟨hal-02881133⟩
  • B. Hervier, Y. Uzunhan, Eric Hachulla, Olivier Benveniste, H. Nunes, et al.. Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies.. European Respiratory Journal, 2011, 37 (3), pp.714-7. ⟨10.1183/09031936.00104310⟩. ⟨hal-00873290⟩
  • Sandrine Larue, Thierry Maisonobe, Olivier Benveniste, Catherine Chapelon-Abric, Olivier Lidove, et al.. DISTAL MUSCLE INVOLVEMENT IN GRANULOMATOUS MYOSITIS CAN MIMIC INCLUSION BODY MYOSITIS. Journal of Neurology, Neurosurgery and Psychiatry, 2010, 82 (6), pp.674. ⟨10.1136/jnnp.2009.190751⟩. ⟨hal-00591161⟩
  • Yves Allenbach, Sounkary Solly, Sylvie Grégoire, Odile Dubourg, Benoit Salomon, et al.. Role of regulatory T cells in a new mouse model of experimental autoimmune myositis.. American Journal of Pathology, 2009, 174 (3), pp.989-98. ⟨10.2353/ajpath.2009.080422⟩. ⟨hal-00420196⟩
  • Philippe Morlat, Edwidge Pereira, Pascal Clayette, Nathalie Derreudre-Bosquet, Jean-Luc Ecobichon, et al.. Early evolution of plasma soluble TNF-alpha p75 receptor as a marker of progression in treated HIV-infected patients.. AIDS Research and Human Retroviruses, 2008, 24 (11), pp.1383-9. ⟨10.1089/aid.2007.0293⟩. ⟨inserm-00350155⟩
  • Yohan Georges, Yves Allenbach, Xavier Ariza, Jean-Marc Campagne, Jordi Garcia. An Efficient, Stereoselective Approach to syn-1,2-Diols Protected as Cyclic Carbonates. Journal of Organic Chemistry, 2004, 69, pp.7387. ⟨10.1021/jo048985g⟩. ⟨hal-00165650⟩

Conference papers

  • Olivier Benveniste. Refractory myositides.. XVIth UCLouvain Review Course on Systemic Rheumatic Diseases, Nov 2022, Bruxelles, Belgium. ⟨hal-03864159⟩
  • Olivier Benveniste. Les myopathies inflammatoires en 2022 : de la physiopathologie aux traitements ciblés. 17ème Journées Scientifiques de la Société Tunisienne d’Immunologie, Nov 2022, Hammamet, Tunisie. ⟨hal-03864162⟩
  • Yves Allenbach. 256th ENMC International Workshop: Myositis specific autoantibodies (MSAab). 13ième Journée Interdisciplinaire du Muscle Inflammatoire, Sep 2022, Paris, France. ⟨hal-03835350⟩
  • Yves Allenbach. Quoi de neuf dans la prise en charge des dermatomyosites à anti-MDA5 sévères ?. 13ième Journée du Muscle Inflammatoire, Sep 2022, Paris, France. ⟨hal-03835354⟩
  • Olivier Benveniste. Inflammatory Myopathies and Innovative Therapies. TMA’s Annual Patient Conference, Sep 2022, Orlando, United States. ⟨hal-03864169⟩
  • Yves Allenbach. Acute ILD MdA5. 15th International Congress on lung transplantation, Sep 2022, Paris, France. ⟨hal-03834287⟩
  • Yves Allenbach. Q/A with medical advisory board breakouts - myotoxicity. 2022 International Annual Patient Conference, Sep 2022, Orlando, United States. ⟨hal-03834288⟩
  • Olivier Benveniste. Treatment Options for Idiopathic Inflammatory Myopathies. 17th International Congress on NeuroMuscular Diseases, Jul 2022, Bruxelles, Belgium. ⟨hal-03864178⟩
  • P. Bay, M. Pineton de Chambrun, V. Rothstein, M. Mahevas, A. Roux, et al.. Les échanges plasmatiques ne semblent pas être associés à un meilleur pronostic chez les patients avec une atteinte pulmonaire rapidement progressive d’une dermatomyosite anti-MDA5. 84ème congrès de la SNFMI, Jun 2022, Nantes, France. pp.A99-A100, ⟨10.1016/j.revmed.2022.03.288⟩. ⟨hal-03834088⟩
  • P. Bay, M. Pineton de Chambrun, A. Roux, V. Bunel, A. Combes, et al.. L’assistance extracorporelle en bridge à la transplantation pulmonaire en urgence pour les patients avec une atteinte pulmonaire rapidement progressive d’une dermatomyosite anti-MDA5. 84ème congrès de la SNFMI, Jun 2022, Nantes, France. pp.A122, ⟨10.1016/j.revmed.2022.03.320⟩. ⟨hal-03834086⟩
  • Olivier Benveniste. Inclusion Body Myositis in 2022: from physiopathogenesis to clinical trials. 4th Global Conference On Myositis,, Jun 2022, Prague, Czech Republic. ⟨hal-03864190⟩
  • Lotta Plomp, Hortense Chassepot, Olivier Benveniste, Yves Allenbach. Immune checkpoint inhibitor -related myotoxicity: musculoskeletal and/or neuromuscular junction disorder?. 4th GLOBAL CONFERENCE ON MYOSITIS 2022 (GCOM 2022), Jun 2022, Prague, Czech Republic. ⟨hal-03834096⟩
  • Yves Allenbach. Myositis triggered by checkpoint inhibitors. 4th Global Conference On Myositis (GCOM 2022), Jun 2022, Prague, Czech Republic. ⟨hal-03832584⟩
  • Sami Mensi, Olivier Benveniste, Yves Allenbach. Use of 18-FDG PET-CT in idiopathic inflammatory myopathies, a retrospective series of 93 examinations. A tool with uncertain performances. 4th Global Conference on Myositis (GCOM 2022), Jun 2022, Prague, Czech Republic. ⟨hal-03834099⟩
  • Yves Allenbach. les syndromes antisynthétases et MDA5. 12e colloque fribourgeois de rhumatologie, Apr 2022, Fribourg, Suisse. ⟨hal-03835085⟩
  • Ryan Hum, James Lilleker, Janine Lamb, William Ollier, Guochung Wang, et al.. P222 Clinical features of extra-muscular disease in dermatomyositis and anti-synthetase syndrome patients with skin involvement classified by presence of disease-specific autoantibodies: results from the EuroMyositis registry. British Society for Rheumatology Annual Conference, BSR 2022, Apr 2022, Glasgow, United Kingdom. ⟨10.1093/rheumatology/keac133.221⟩. ⟨hal-03831256⟩
  • Abdellah Tebani, Franklin Ducatez, Wladimir Mauhin, Agnès Boullier, Carine Pilon, et al.. Dissecting Fabry disease biological plasticity using network-based metabolic phenotyping. WORLDSymposium™ 2022, Feb 2022, San diego, United States. pp.S118, ⟨10.1016/j.ymgme.2021.11.314⟩. ⟨hal-03831262⟩
  • Pierre Bay, Marc Pineton de Chambrun, Vincent Rothstein, Matthieu Mahevas, Nicolas de Prost, et al.. Plasma exchange are not associated with better outcome in MDA5 rapidly-progressive interstitial lung disease. French Intensive Care Society International Congress 2022, 2022, paris, France. pp.54, ⟨10.1186/s13613-022-01016-6⟩. ⟨hal-03831253⟩
  • S. Mensi, H. Chassepot, D. Kharroubi, L. Plomp, B. Abbar, et al.. Valeur diagnostique de la TEP-TDM au 18-FDG dans les myosites secondaires aux inhibiteurs de point de contrôle immunitaires. 83ème congrès de la SNFMI, Dec 2021, Paris, France. pp.A267-A268, ⟨10.1016/j.revmed.2021.10.207⟩. ⟨hal-03834079⟩
  • A. Chaudier, Yves Allenbach, A. Mekinian, C. Richez, M.E. Truchetet, et al.. Tolérance et efficacité des thérapies ciblées prescrites dans des indications hors AMM au cours des maladies auto-immunes systémiques réfractaires : données des 100 premiers patients inclus dans le registre TATA (TArgeted Therapy in Auto-immune Diseases). 83e Congrès de la SNFMI, Dec 2021, Paris, France. pp.A407, ⟨10.1016/j.revmed.2021.10.119⟩. ⟨hal-03834090⟩
  • L. Bolko, S. Louis-Leonard, L. Kanagaratnam, C. Pineau, C. Anquetil, et al.. Précision diagnostique de l’électroneuromyogramme dans les myosites. 83ème congrès de la SNFMI, Dec 2021, Paris, France. pp.A265-A266, ⟨10.1016/j.revmed.2021.10.204⟩. ⟨hal-03834082⟩
  • Yves Allenbach, G. Mercy, J.F. Deux, F. Foissac, Y. Schoindre, et al.. Performances de l’IRM musculaire pour le diagnostic des myopathies auto-immunes : étude prospective multicentrique (DARWIM). 83ème congrès de la SNFMI, Dec 2021, Paris, France. pp.A266, ⟨10.1016/j.revmed.2021.10.205⟩. ⟨hal-03834081⟩
  • H. Chassepot, L. Plomp, S. Mensi, D. Psimaras, M. Touat, et al.. Myotoxicité liée aux inhibiteurs de points de contrôle immunitaire: trouble de l’appareil musculaire et/ou de la jonction neuromusculaire?. 83ème congrès de la SNFMI, Dec 2021, Paris, France. pp.A269, ⟨10.1016/j.revmed.2021.10.209⟩. ⟨hal-03834073⟩
  • P. Breillat, K. Mariampillai, P. Martins, P. Legendre, B. Dunogué, et al.. Spectre clinique et pronostic des connectivites à anti PM-Scl ; une étude multicentrique incluant 128 patients. 83ème congrès de la SNFMI, Dec 2021, Paris, France. pp.A91-A92, ⟨10.1016/j.revmed.2021.03.316⟩. ⟨hal-03834083⟩
  • K. Gourbeyre-Masson, O. Benveniste, B. Colombe, Yves Allenbach, N. Terzi, et al.. Profil et pronostic des myopathies inflammatoires en unité de soins intensifs: une étude rétrospective et multicentrique. 83ème congrès de la SNFMI, Dec 2021, Paris, France. pp.A265, ⟨10.1016/j.revmed.2021.10.203⟩. ⟨hal-03834072⟩
  • J. Demortier, M. Vautier, O. Chosidow, L. Gallay, D. Bessis, et al.. Dermatomyosite à anticorps anti-SAE: étude descriptive et comparative à un groupe de dermatomyosites SAE-négatives. 83ème congrès de la SNFMI, Dec 2021, Paris, France. pp.A264, ⟨10.1016/j.revmed.2021.10.202⟩. ⟨hal-03834077⟩
  • S. Mensi, P. Daniel, D. Kharroubi, Yves Allenbach, A. Kas, et al.. Emploi de la TEP-TDM au 18-FDG dans les myopathies inflammatoires, description rétrospective sur une série de 93 examens, un outil aux performances encore incertaines. 83ème congrès de la SNFMI8, Dec 2021, Paris, France. pp.A266-A267, ⟨10.1016/j.revmed.2021.10.206⟩. ⟨hal-03834084⟩
  • J.E. Gottenberg, A. Chaudier, Yves Allenbach, A. Mékinian, C. Richez, et al.. Tolérance et efficacité des thérapies ciblées prescrites hors AMM au cours des maladies auto-immunes systémiques réfractaires : données des 100 premiers patients inclus dans le registre TATA (TArgeted Therapy in Autoimmune Diseases). 34e Congrès français de la SFR, Dec 2021, Paris, France. pp.A54, ⟨10.1016/j.rhum.2021.10.081⟩. ⟨hal-03834093⟩
  • Olivier Benveniste. Actual landscape of (auto-immune) inflammatory myopathies. Portuguese Congress of Neuromuscular Disorders, Oct 2021, NA, Portugal. ⟨hal-03831945⟩
  • Olivier Benveniste. The Rapamycin Study for IBM. 2021 Muscle Study Group Scientific Annual Meeting, Oct 2021, NA, United States. ⟨hal-03831935⟩
  • Yves Allenbach. Myosite et IRM musculaire. 13éme édition du JIMI (Journée Interdisciplinaire du Muscle Inflammatoire), Sep 2021, Paris, France. ⟨hal-03835505⟩
  • Yves Allenbach. What's new in Myositis ?. German Rheumatology Congress (virtual), Sep 2021, Berlin, Germany. ⟨hal-03834281⟩
  • Eveline Van Gompel, Catia Cerqueira, Begum Horuluoglu, Angeles Shunashy Galindo- Feria, Karine Chemin, et al.. Anti-MDA5 autoantibodies in myositis patients specifically target the Helicase domains of the MDA5 protein. 6th European Congress of Immunology virtual, Sep 2021, Nottingham, United Kingdom. ⟨hal-03831292⟩
  • Olivier Benveniste. Inflammatory myopathies: advocating better classification and care. Seminar of the Swiss Rheumatology Academia, Jun 2021, NA, Switzerland. ⟨hal-03831924⟩
  • Olivier Benveniste. Clinical diagnostic aspects in myositis. 12th European Congress of Neuropathology virtual, May 2021, Copenhague, Denmark. pp.217-241, ⟨10.5414/NPP40217⟩. ⟨hal-03831288⟩
  • Céline Anquetil, Olivier Benveniste, Javid J. Moslehi, Douglas B. Johnson, Bénédicte Lebrun-Vignes, et al.. immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication amongst rheumatic and musculoskeletal toxicities. 12th International congress on Autoimmunity virtual, May 2021, Athènes, Greece. ⟨hal-03834293⟩
  • Olivier Benveniste. Inflammatory Autoimmune Myopathies. 16th International Congress on Neuromuscular Diseases (ICNMD202), May 2021, Valencia, Spain. ⟨hal-03831903⟩
  • Olivier Benveniste. Inflammatory myopathies and lung involvement. Mayo Clinic virtual symposium on Autoimmunity and the Lung, Nov 2020, Orlando, United States. ⟨hal-03831916⟩
  • Yves Allenbach. Myosites et Jak inhibiteurs. De l’immunopathologie aux biothérapies : Actualités et Controverses, Nov 2020, Paris, France. ⟨hal-03834274⟩
  • Yves Allenbach. Myotoxicité. ISNI 2020 - 15E CONGRÈS DE LA SOCIÉTÉ INTERNATIONALE DE NEURO IMMUNOLOGIE, Nov 2020, Nice, France. ⟨hal-03834279⟩
  • Olivier Benveniste. Inflammatory Myopathies: Issues in diagnosis and management. Virtual Agrim Neurology Update 2020, Oct 2020, NA, France. ⟨hal-03831909⟩
  • Yves Allenbach. Atteinte cardiaque des myosites. Carrefour des spécialités -Médecine interne et Cardiologie, Oct 2020, Paris, France. ⟨hal-03834283⟩
  • Yves Allenbach. Flash Talks : quoi de neuf dans les myopathies inflammatoires ?. RENCONTRES EN IMMUNOLOGIE ET IMMUNOTHERAPIE PRATIQUES - RIIP 2020, Sep 2020, Paris, France. ⟨hal-03834273⟩
  • Yves Allenbach. Muscle inflammatoire. Rencontres en Immunologie et immunothérapie pratiques, Sep 2020, Paris, France. ⟨hal-03832602⟩
  • Yves Allenbach. Myocardites : Quel bilan ? quelles étiologies?. Rencontre TUC - GIHP et GACI, Sep 2020, Paris, France. ⟨hal-03835081⟩
  • Olivier Benveniste. Myositis, new treatment options. EULAR 2020 E-Congress, Jun 2020, Berlin, Germany. ⟨hal-03831898⟩
  • Alexander Oldroyd, Paul New, Janine Lamb, William Ollier, Robert Cooper, et al.. Earlier cancer diagnosis after myositis onset is associated with improved long term survival: results from UK, French and Czech cohorts. 2020 Annual Conference of the British Society for Rheumatology, BSR 2020, Apr 2020, Glasgow, United Kingdom. ⟨10.1093/rheumatology/keaa110.032⟩. ⟨hal-03831704⟩
  • Yves Allenbach. Rheumatic toxicities associated with immune checkpoint inhibitors: The severity of myositis. NIH-AACR CANCER, AUTOIMMUNITY, AND IMMUNOLOGY CONFERENCE, Mar 2020, Bethesda, United States. ⟨hal-03834267⟩
  • Soumeya Bekri, Lénaig Abily-Donval, Wladimir Mauhin, Celine Lesueur, Olivier Benveniste, et al.. Predictive biological patterns in Fabry disease revealed by integrative omics machine learning analysis. WORLDSymposium™ 2020, Feb 2020, Orlando, United States. pp.S29, ⟨10.1016/j.ymgme.2019.11.047⟩. ⟨hal-03831698⟩
  • Olivier Benveniste. Inflammatory Myopathies. The importance of being well classified!. . Departments of Neurology and Physiology and Biophysics (and the Institute of Immunology)., Jan 2020, Irvine, United States. ⟨hal-03831886⟩
  • Yves Allenbach. Imagerie et explorations innovantes au cours des myopathies auto-immunes. 80ieme Congrès de la SNFMI, Dec 2019, Limoges, France. pp.A27-A29, ⟨10.1016/j.revmed.2019.10.340⟩. ⟨hal-03834254⟩
  • S. Presente, C. Allonier, P. Rufat, N. Champtiaux, A. Rigolet, et al.. Pronostic des patients hospitalisés en médecine interne après passage aux urgences : le rôle du médecin généraliste. 80ème congrès de la SNFMI, Dec 2019, Limoges, France. ⟨hal-03834045⟩
  • L. Bolko, K. Didier, S. Toquet, A. Servettaz, N. Champtiaux, et al.. Signification pronostique du titre d’anticorps anti-Jo1 au cours du syndrome des anti-synthétases. 80ème congrès de la SNFMI, Dec 2019, Limoges, France. ⟨hal-03834050⟩
  • B. Salvador, A. Cypierre, Yves Allenbach, E. Liozon, A.L. Fauchais, et al.. Amylose AL : une autre grande simulatrice. 80ème congrès de la SNFMI, Dec 2019, Limoges, France. ⟨hal-03834054⟩
  • C. Anquetil, J.E. Salem, A. Manouchehri, O. Lambotte, B. Lebrun-Vignes, et al.. Phénotype et pronostic des atteintes systémiques induites sous inhibiteurs de check-points immunitaires. 80ème congrès de la SNFMI, Dec 2019, Limoges, France. ⟨hal-03834068⟩
  • S. Toquet, B. Granger, Y. Uzunhan, G. Leroux, R. Paule, et al.. La dermatomyosite associée à l’anticorps anti-MDA5 est une maladie saisonnière : un argument pour un facteur déclenchant viral. 80ème congrès de la SNFMI, Dec 2019, Limoges, France. ⟨hal-03834042⟩
  • Yves Allenbach. De l’immunologie à la pratique : les auto-anticorps au coeur des myopathies auto-immunes. Journée Immunosemm, Nov 2019, Paris, France. ⟨hal-03835074⟩
  • Yves Allenbach. Myopathies inflammatoires (hors myosite à inclusion) : quels traitements fondés sur des preuves ?. Deuxième journée nationale d’ophtalmologie et de médecine interne fondée sur des preuves, Nov 2019, Paris, France. ⟨hal-03834252⟩
  • Yves Allenbach. Une face sombre de l’immunothérapie en cancérologie : la toxicité musculaire. 17èmes Journées de la Société Française de Myologie, Nov 2019, Marseille, France. ⟨hal-03834264⟩
  • Harmen Reyngoudt, Benjamin Marty, Jean-Marc Boisserie, Julien Le Louër, Cedi Koumako, et al.. Can global muscle segmentation detect changes in neuromuscular disorders using quantitative nuclear magnetic resonance imaging?. Imaging in Neuromuscular Disease 2019: Second International Conference on Imaging in Neuromuscular Disease, Nov 2019, Berlin, Germany. pp.S1-S62, ⟨10.3233/JND-199002⟩. ⟨hal-03831354⟩
  • Céline Anquetil, Olivier Benveniste, Douglas Johnson, Bénédicte Lebrun-Vignes, Joe-Elie Salem, et al.. Rheumatic toxicities associated with immune checkpoint inhibitors: An observational, retrospective, pharmacovigilance study. American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2019, Nov 2019, Atlanta, United States. pp.1-5420, ⟨10.1002/art.41108⟩. ⟨hal-03831676⟩
  • C. Anquetil, J. Salem, B. Lebrun-Vignes, D. Johnson, A. Mammen, et al.. Immune checkpoint inhibitor-associated myositis: a new entity with a poor prognosis. 24th International Annual Congress of the World Muscle Society (WMS), Oct 2019, Copenhague, Denmark. pp.S121, ⟨10.1016/j.nmd.2019.06.301⟩. ⟨hal-03832083⟩
  • Yves Allenbach. Traitements des myopathies nécrosantes:​ les recommandations de l’ENMC et les perspectives. 11 eme Journée du Interdisciplinaire du Muscle Inflammatoire, Sep 2019, Paris, France. ⟨hal-03835510⟩
  • Yves Allenbach. Immune Mediated Necortizing Myopathies and Antibodies. 14th Dresden Symposium on Autoantibodies, Sep 2019, Dresden, Germany. ⟨hal-03834251⟩
  • Olivier Benveniste. Myositides: the importance of being well classified, from physiopathogenesis to targeted treatments. 44th Oxford Muscle Symposium, Jul 2019, Oxfard, United Kingdom. ⟨hal-03831882⟩
  • Camille Houssais, Jean-Baptiste Noury, Yves Allenbach, Laure Gallay, Florence Assan, et al.. Myositis in patients with primary Sjögren's syndrome: data from a French nationwide survey. Annual European Congress of Rheumatology. EULAR 2019, Jun 2019, Madrid, Spain. pp.1171.1-1171, ⟨10.1136/annrheumdis-2019-eular.3474⟩. ⟨hal-03831358⟩
  • Olivier Benveniste. Idiopathic Inflammatory Myopathies: the importance of being well classified, from physiopathogenesis to targeted treatments. 4th Neuromuscular Disorders’ Time Symposium, May 2019, Shanghai, China. ⟨hal-03831875⟩
  • Yves Allenbach. Diagnosis of inflammatory myopathies. MIRCIM 2019, May 2019, Cracovie, Poland. ⟨hal-03834255⟩
  • Olivier Benveniste. Inclusion Body Myositis from physiopathogenesis to treatment. Neurology Grand Rounds, Apr 2019, Kansas City, United States. ⟨hal-03831865⟩
  • Olivier Benveniste. Recent advance in myositis classification and treatments. Myositis Regional Conference, Apr 2019, Kansas City, United States. ⟨hal-03831862⟩
  • Olivier Benveniste. Inflammatory Myopathies: the importance of being well classified, from physiopathogenesis to targeted treatments. Allergy, Clinical Immunology & Rheumatology Divisional Conference, Apr 2019, Kansas City, United States. ⟨hal-03831870⟩
  • Olivier Benveniste. Mentorship & Academic Promotion: The French System. 3rd Global Conference On Myositis, Mar 2019, Berlin, Germany. ⟨hal-03831858⟩
  • Olivier Benveniste. New classification and targeted therapy in idiopathic inflammatory myopathies. Ninth France-Israel Symposium in Rheumatic Diseases, Feb 2019, Haifa, Israel. ⟨hal-03831855⟩
  • Olivier Benveniste. Serology in Inflammatory Myopathies. 16th Groninger Symposium Systeemziekten, Feb 2019, Groningen, Netherlands. ⟨hal-03831852⟩
  • O. Landon-Cardinal, D. Bachasson, P. Guillaume-Jugnot, M. Vautier, N. Champtiaux, et al.. Évaluation de l’activité physique par accélérométrie de poignet dans le suivi des patients avec myopathies auto-immunes. 78e congrès de la SNFMI, Dec 2018, Grenoble, France. pp.A1, ⟨10.1016/j.revmed.2018.10.381⟩. ⟨hal-03833966⟩
  • C. Anquetil, J.E. Salem, B. Lebrun-Vignes, D.B. Johnson, A.L. Mammen, et al.. Myosites induites par les Inhibiteurs de Checkpoint Immunitaires : une nouvelle myopathie auto-immune associée à une atteinte myocardique de mauvais pronostic. 78e congrès de la SNFMI, Dec 2018, Grenoble, France. pp.A1, ⟨10.1016/j.revmed.2018.10.381⟩. ⟨hal-03834040⟩
  • M. Vautier, J. Schmidt, A. Berezne, N. Cordel, P. Duffau, et al.. Dermatomyosite et anticorps anti-SAE : des patients peu déficitaires avec un risque accru de troubles de la déglutition et de pneumopathie organisée. 78e congrès de la SNFMI, Dec 2018, Grenoble, France. pp.A1, ⟨10.1016/j.revmed.2018.10.381⟩. ⟨hal-03834004⟩
  • M. Peyre, N. Zahr, F. Cohen Aubart, Yves Allenbach, O. Benveniste, et al.. Utilité de la mesure de l’aire sous la courbe du Mycophénolate Mofétil chez les patients traités pour myopathies inflammatoires. 78e congrès de la SNFMI, Dec 2018, Grenoble, France. pp.A1, ⟨10.1016/j.revmed.2018.10.381⟩. ⟨hal-03834035⟩
  • Yves Allenbach. Club Médecine interne Myosite. 78ieme Congrès de la SNFMI, Dec 2018, Grenoble, France. ⟨hal-03834104⟩
  • J. Galland, M. Pha, P. Guillaume-Jugnot, N. Abisror, G. Grateau, et al.. Bienvenue au 78e congrès de la SNFMI au cœur des Alpes. 78e congrès de la SNFMI, Dec 2018, Grenoble, France. pp.A1, ⟨10.1016/j.revmed.2018.10.381⟩. ⟨hal-03833954⟩
  • O. Mangin, J.P. Bertocchio, S. Baron, G. Maruani, P. Houillier, et al.. Estimation du débit de filtration glomérulaire : des insuffisances rénales méconnues au cours de la myosite à inclusions. 78e congrès de la SNFMI, Dec 2018, Grenoble, France. pp.A1, ⟨10.1016/j.revmed.2018.10.381⟩. ⟨hal-03833994⟩
  • Yves Allenbach. Classification des Myosite par les Anticorps spécifiques des myosites. 78ième Congrès de la SNFMI, Dec 2018, Grenoble, France. ⟨hal-03834105⟩
  • N. Wesner, A. Uruha, N. Costedoat-Chalumeau, A. Rigolet, Y. Schoindre, et al.. Myosites associées aux anticorps anti-RNP : un phénotype homogène avec une atteinte nécrosante de bon pronostic et des manifestations systémiques persistantes. 78e congrès de la SNFMI, Dec 2018, Grenoble, France. pp.A113, ⟨10.1016/j.revmed.2018.03.363⟩. ⟨hal-03833974⟩
  • Yves Allenbach, L. Bolko, C. Anquetil, N. Wesner, D. Amelin, et al.. Dosage de l’interféron par technologie SIMOA au cours des myopathies inflammatoires idiopathiques : un biomarqueur diagnostique et d’activité. 78e congrès de la SNFMI, Dec 2018, Grenoble, France. pp.A1, ⟨10.1016/j.revmed.2018.10.381⟩. ⟨hal-03834002⟩
  • C. Koumakou, O. Landon-Cardinal, B. Granger, M. Vautier, H. Reyngoudt, et al.. IRM musculaire corps entier au cours des myopathies nécrosantes auto-immunes : involution graisseuse sévère axiale et pelvi-fémorale. 78e congrès de la SNFMI, Dec 2018, Grenoble, France. pp.A1, ⟨10.1016/j.revmed.2018.10.381⟩. ⟨hal-03833970⟩
  • Yves Allenbach. Complications auto-immunes des checkpoint inhibiteurs : le modèle des myosites et des myocardites. De l’immunopathologie aux biothérapies : Actualités et Controverses, Nov 2018, Paris, France. ⟨hal-03834249⟩
  • Yves Allenbach. Nouveaux autoanticorps, nouvelles maladies. Congrès de la SFM, Nov 2018, Brest, France. ⟨hal-03834106⟩
  • Yves Allenbach. Traitement par inhibiteurs de JAK des formes sévères de dermatomyosite de l’adulte et de l’enfant. 2e journée du Centre de référence des maladies rhumatologiques et auto-immunes rares de l’enfant, Nov 2018, Paris, France. ⟨hal-03834244⟩
  • Yves Allenbach. Myosites : formes graves et prise en charge en réanimation. Carrefour des spécialités : médecine interne et réanimation, Nov 2018, Paris, France. ⟨hal-03834284⟩
  • Loïs Bolko, Ségolène Toquet, Océane Landon-Cardinal, Karim Dorgham, Céline Anquetil, et al.. IFN level assessed by ultrasensitive detection technology in myositis patient: A promising biomarker of disease activity in dermatomyositis and anti-synthetase syndrome. American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2018, Oct 2018, Chicago, United States. pp.1-3584, ⟨10.1002/art.40700⟩. ⟨hal-03831328⟩
  • Céline Anquetil, Joe-Elie Salem, Benedicte Lebrun-Vignes, Douglas B Johnson, Andrew Mammen, et al.. Immune Checkpoint Inhibitor-Associated Myositis: A CharacteristicPhenotype with a Poor Outcome Related to Concomitant Myocarditis. American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2018, Oct 2018, Chicago, United States. pp.1-3584, ⟨10.1002/art.40700⟩. ⟨hal-03831343⟩
  • Yves Allenbach. Actualités sur les maladies autoimmunes - Actualités sur les myosites. Journée Maladie Auto-Immune - Kremlin Bicêtre, Oct 2018, Paris, France. ⟨hal-03835079⟩
  • Olivier Benveniste. Inflammatory Myopathies. Kongress der Deutschen Gesellschaft für Rheumatologie, Sep 2018, Mannheim, Germany. ⟨hal-03831847⟩
  • Yves Allenbach. Revue de la classification et des critères ACR/EULAR. 10 Journée Interdisciplinaire du Muscle Inflammatoire, Sep 2018, Paris, France. ⟨hal-03835514⟩
  • Olivier Benveniste. Understanding necrotizing myopathy. TMA’s Annual Patient Conference, Sep 2018, Louisville, United States. ⟨hal-03831843⟩
  • Yves Allenbach. Cancer and Myositis. 15th International Congress of Neuromuscular Diseases (ICNMD 2018), Jul 2018, Vienne, Austria. ⟨hal-03834102⟩
  • Olivier Benveniste. Inflammatory myopathies in France, from classification to physiogenesis. 11th Japanese-French workshop on NMD, Jun 2018, Tokyo, Japan. ⟨hal-03831839⟩
  • Yves Allenbach. Immune-mediated necrotizing myopathies and antibodies. 11TH INTERNATIONAL CONGRESS ON AUTOIMMUNITY, May 2018, Lisbonne, Portugal. ⟨hal-03834111⟩
  • Olivier Benveniste. The classification and physiopathogenesis of the main idiopathic inflammatory myopathies.. 5th Chinese Inflammatory Myopathies Meeting,, Apr 2018, Beijing, China. ⟨hal-03831834⟩
  • Olivier Benveniste. Les nouvelles myopathies inflammatoires : apport de l’immunologie dans leur classification.. 20ème Congrès National de Médecine Interne Tunisien, Mar 2018, Hammamet, Tunisie. ⟨hal-03831830⟩
  • Olivier Benveniste. Actualités thérapeutiques des myosites. 20ème Congrès National de Médecine Interne Tunisien, Mar 2018, Hammamet, Tunisie. ⟨hal-03831827⟩
  • Yves Allenbach. Dermatomyositis and IFN. Euromyositis registry and MYONET meeting, Feb 2018, Prague, Czech Republic. ⟨hal-03834100⟩
  • Yves Allenbach. Nouvelle classification des myopathies inflammatoires : place des anticorps spécifiques. Académie nationale de médecine, Jan 2018, Paris, France. ⟨hal-03834242⟩
  • O. Benveniste, J.Y. Hogrel, M. Annoussamy, A. Rigolet, B. Hervier, et al.. Premiers résultats prometteurs de l’essai rapamycine versus placebo pour le traitement de la myosite à inclusions (RAPAMI). 76eme Congrès de la SNFMI Franco-Maghrébin, Dec 2017, Paris, France. ⟨hal-03833928⟩
  • G. Dzangué-Tchoupou, Yves Allenbach, C. Aurélien, D. Amelin, W. Mauhin, et al.. Cytométrie de masse : caractéristiques phénotypiques de la réponse immunitaire systémique au cours des myosites. 76eme Congrès de la SNFMI Franco-Maghrébin, Dec 2017, Paris, France. ⟨hal-03833932⟩
  • K. Mariampillai, B. Granger, M. Guiguet, D. Amelin, E. Hachulla, et al.. Une nouvelle classification des myopathies inflammatoires idiopathiques basée sur des manifestations cliniques et les anticorps spécifiques des myosites. 76ÈME CONGRÈS DE LA SNFMI - FRANCO-MAGHRÉBIN, Dec 2017, Paris, France. ⟨hal-03833849⟩
  • L. Gallay, N. Streichenberger, O. Benveniste, Yves Allenbach. Myosite focale : une maladie méconnue. 76eme Congrès de la SNFMI Franco-Maghrébin, Dec 2017, Paris, France. ⟨hal-03833916⟩
  • G. Monseau, O. Landon-Cardinal, W. Stenzel, Y. Schoindre, K. Mariampillai, et al.. Dermatomyosites (DM) à anticorps anti-Mi2 revisitées : DM pure avec nécrose musculaire et haut risque de malignité associée. 76eme Congrès de la SNFMI Franco-Maghrébin, Dec 2017, Paris, France. ⟨hal-03833897⟩
  • O. Landon-Cardinal, Yves Allenbach, A. Soulages, A. Rigolet, B. Hervier, et al.. Rituximab dans le traitement des MNAI anti-HMGCR : efficacité modeste et IgIV-dépendance. 76eme Congrès de la SNFMI Franco-Maghrébin, Dec 2017, Paris, France. ⟨hal-03833941⟩
  • A. Uruha, Yves Allenbach, T. Maisonobe, S. Léonard-Louis, J.L. Charuel, et al.. Myxovirus resistance A : un marqueur histologique diagnostique pour la dermatomyosite. 76eme Congrès de la SNFMI Franco-Maghrébin, Dec 2017, Paris, France. ⟨hal-03833925⟩
  • S. Toquet, O. Landon-Cardinal, P. Guillaume-Jugnot, N. Champtiaux, L. Ladislau, et al.. Les inhibiteurs de la voie des Janus-kinases : un traitement prometteur de la dermatomyosite pour inhiber de la voie de l’interféron,. 76eme Congrès de la SNFMI Franco-Maghrébin, Dec 2017, Paris, France. ⟨hal-03833946⟩
  • Yves Allenbach, A. Rigolet, S. Louis-Leonard, E. Salort-Campana, L. Gilardin, et al.. Myopathie axiale vacuolaire avec rigidité : une nouvelle entité reliée aux gammapathies monoclonales. 76eme Congrès de la SNFMI Franco-Maghrébin, Dec 2017, Paris, France. ⟨hal-03833911⟩
  • W. Mauhin, L. Arouche-Delaperche, D. Amelin, J. Dimitrov, Yves Allenbach, et al.. Les anticorps anti-HMGCoA-reductase associés aux myopathies nécrosantes auto-immunes ont une forte affinité pour l’HMGCoA-reductase sans pour autant l’inhiber. 76eme Congrès de la SNFMI Franco-Maghrébin, Dec 2017, Paris, France. ⟨hal-03833921⟩
  • O. Benveniste, D. Bachasson, O. Landon-Cardinal, N. Champtiaux, L. Gilardin, et al.. Une solution nouvelle pour l’évaluation des myosites : la mesure de l’activité physique quotidienne par accéléromètrie. 76eme Congrès de la SNFMI Franco-Maghrébin, Dec 2017, Paris, France. ⟨hal-03833904⟩
  • Olivier Benveniste, Jean-Yves Hogrel, Melanie Annoussamy, Damien Bachasson, Aude Rigolet, et al.. Rapamycin vs. Placebo for the Treatment of Inclusion Body Myositis: improvement of the 6 min walking distance, a functional scale, the FVC and muscle quantitative MRI. 2017 ACR/ARHP Annual Meeting, Nov 2017, San Diego, United States. pp.1-3584. ⟨hal-03831822⟩
  • O. Landon-Cardinal, G. Monseau, Y. Schoindre, A. Rigolet, N. Champtiaux, et al.. Anti-Mi2 dermatomyositis revisited: pure DM phenotype with muscle fiber necrosis and high risk of malignancy. 22nd International Congress of the World Muscle Society, Oct 2017, Saint Malo, France. pp.S153, ⟨10.1016/j.nmd.2017.06.218⟩. ⟨hal-01664160⟩
  • Yves Allenbach. Myopathie et gammapathie Monoclonae. 9 eme Journée Interdisciplinaire du Muscle inflammatoire, Sep 2017, Paris, France. ⟨hal-03835519⟩
  • Olivier Benveniste. Promising Research in Inclusion Body Myositis. TMA’s Annual Patient Conference, Sep 2017, San Diego, United States. ⟨hal-03831792⟩
  • Olivier Benveniste. Myositis-specific antibodies and what they tell us about the different forms of myositis.. 2nd Global Conference on Myositis, May 2017, Potomac, United States. ⟨hal-03831781⟩
  • Olivier Benveniste. Prognosis in adult myositis. 2nd Global Conference on Myositis, May 2017, Potomac, United States. ⟨hal-03831785⟩
  • Olivier Benveniste. Classification and treatments of myositis. Third Lebanon congress of Internal Medicine, Jan 2017, Beyrouth, Lebanon. ⟨hal-03831774⟩

Poster communications

  • Mridul Johari, Daphne Wijnbergen, Alaa Khan, Pedro Machado, Henry Houlden, et al.. Elucidating the molecular biology of Inclusion body Myositis through multi-omics analysis. Solve-RD, Solving the unsolved Rare Diseases, Final Meeting 2023, Apr 2023, Prague, Czech Republic. ⟨hal-04086230⟩
  • Céline Anquetil, Nozomu Tawara, Maxime Lecerf, Damien Amelin, Alexandrine Mahoudeau, et al.. Antigenic targets in anti-SRP immune-mediated necrotizing myopathy. 4th Global Conference On Myositis (GCOM 2022), Jun 2022, Prague, Czech Republic. ⟨hal-03832564⟩
  • Alexandrine Mahoudeau, Céline Anquetil, Nozomu Tawara, Hossein Khademian, Damien Amelin, et al.. Myostatin in idiopathic inflammatory myopathies: serum assessment and disease activity. 4th Global Conference On Myositis (GCOM 2022), Jun 2022, Prague, Czech Republic. ⟨hal-03832567⟩
  • Loïs Bolko, Sarah Leonard-Louis, Lukshe Kanagaratnam, Charlotte Pineau, Jean-Hugues Salmon, et al.. Diagnostic accuracy of electromyogram for myositis. 4th Global Conference On Myositis (GCOM 2022), Jun 2022, Prague, Czech Republic. ⟨hal-03832588⟩
  • Corinna Preusse, Andreas Hentschel, Albert Sickmann, Yves Allenbach, Olivier Benveniste, et al.. Upregulation of structural proteins in immune-mediated necrotizing myopathy is independent of underlying autoantibodies. 4TH GLOBAL CONFERENCE ON MYOSITIS 2022, Jun 2022, Prague, Czech Republic. ⟨hal-03832549⟩
  • Yves Allenbach, Guillaume Mercy, Jean-Francois Deux, Frantz Foissac, Yoland Shoindre, et al.. Diagnosis accuracy of muscule MRI for autoimmune myopathies: Multicentric prospective study (DARWIM). 4th Global Conference On Myositis (GCOM 2022), Jun 2022, Prague, Czech Republic. ⟨hal-03832571⟩
  • Samy Mensi, Horstense Chassepot, Dris Kharroubi, Lotta Plomp, Baptiste Abbar, et al.. 18-FDG PET-CT diagnostic value in immune checkpoint inhibitor-induced myositis. 4th Global Conference On Myositis (GCOM 2022), Jun 2022, Prague, Czech Republic. ⟨hal-03832576⟩
  • M. Lekieffre, Yves Allenbach, A. Meyer, S. Louis-Léonard, O. Benveniste, et al.. Refining rheumatoid arthritis and myositis overlap: a multicentric French case-series. 4th Global Conference On Myositis (GCOM 2022), Jun 2022, Prague, Czech Republic. ⟨hal-03832585⟩
  • Julian Dal Cin, Céline Anquetil, Mehdi Touat, Lisa Salhi, Hossein Khademian, et al.. Description of macrophages in idiopathic inflammatory myopathies using in-situ RNAseq. 4th Global Conference On Myositis (GCOM 2022), Jun 2022, Prague, Czech Republic. ⟨hal-03832557⟩
  • Chassepot Hortense, Plomp Lotta, Psimaras Dimitri, Maisonobe Thierry, Plu Isabelle, et al.. Immune checkpoint inhibitor-related myotoxicity : Musculoskeletal and/or neuromuscular junction disorder ?. American College of Rheumatology Convergence, ACR 2021, Nov 2021, San Diego, United States. 73 (S9), pp.1-4259, 2021, ⟨10.1002/art.41966⟩. ⟨hal-03831277⟩
  • Alexandrine Mahoudeau, Céline Anquetil, Nozomu Tawara, Hossein Khademian, Damien Amelin, et al.. Myostatin in idiopathic inflammatory myopathies: Seric assessment and disease activity. American College of Rheumatology Convergence, ACR 2021, Nov 2021, San Diego, United States. 73 (S9), pp.1-4259, 2021, ⟨10.1002/art.41966⟩. ⟨hal-03831267⟩
  • Loïs Bolko, Sarah Léonard-Louis, Jean Hugues Salmon, Olivier Benveniste, Yves Allenbach, et al.. Diagnostic accuracy of electromyogram for myositis. American College of Rheumatology Convergence, ACR 2021, Nov 2021, San Diego, United States. 73 (S9), pp.1-4259, 2021, ⟨10.1002/art.41966⟩. ⟨hal-03831303⟩
  • Eveline Van Gompel, Catia Cerqueira, Karine Chemin, Begum Horuluoglu, Angeles Shunashy Galindo- Feria, et al.. MDA5 helicase domains identified as the main targets of anti-MDA5 autoantibodies in european dermatomyositis patients. American College of Rheumatology Convergence, ACR 2021, Nov 2021, San Diego, United States. 73 (S9), pp.1-4259, 2021, ⟨10.1002/art.41966⟩. ⟨hal-03831280⟩
  • Corinna Preuße, Pascale Eede, Lucie Heinzeling, Kiara Freitag, Randi Koll, et al.. NanoString technology distinguishes anti-TIF-1γ+ from anti-Mi-2+ dermatomyositis patients. 12th European Congress of Neuropathology virtual, May 2021, NA, Sweden. 40 (07), pp.149, 2021, ⟨10.5414/NPP40M01⟩. ⟨hal-03831768⟩
  • Thierry Poynard, Olivier Deckmyn, Marika Rudler, Valentina Peta, Yen Ngo, et al.. Performance of serum apolipoprotein-a1 as a sentinel of COVID-19. 71st Annual Meeting of the American Association for the Study of Liver Diseases, AASLD, Nov 2020, Boston, United States. 72 (S1), 2020, ⟨10.1002/hep.31579⟩. ⟨hal-03831756⟩
  • Alexander Oldroyd, Paul New, Janine Lamb, William Ollier, Robert Cooper, et al.. Earlier Cancer Diagnosis after Idiopathic Inflammatory Myopathy Onset Is Associated with Improved Long Term Survival - Results from Four European Cohorts. American College of Rheumatology Convergence, ACR 2020 virtual, Nov 2020, NA, United States. ⟨hal-03831570⟩
  • Loïs Bolko, Kevin Didier, Jean-Hugues Salmon, Makoto Miyara, Segolene Toquet, et al.. Anti-Jo1 Antibody Quantification Serve as a Prognostic Factor in Antisynthetase Syndrom. American College of Rheumatology Convergence, ACR 2020 virtual, Nov 2020, NA, United States. 72 (S10), pp.1-4259, 2020, ⟨10.1002/art.41538⟩. ⟨hal-03831580⟩
  • Alexandre Le Joncour, Corinne Frère, Isabelle Martin-Toutain, Paul Gougis, Pascale Ghillani-Dalbin, et al.. Antiphospholipid Antibodies and Thrombotic Events in COVID-19 Patients Hospitalized in Medicine Ward. ACR Convergence 2020, Nov 2020, Online, United States. , 20 (2), pp.102729, 2021, Elsevier Public Health Emergency Collection. ⟨10.1016/j.autrev.2020.102729⟩. ⟨hal-03831591⟩
  • Chloé Comarmond, Mathilde Leclercq, Gaëlle Leroux, Cindy Marques, Alexandre Le Joncour, et al.. 2019 Novel Coronavirus Disease (COVID-19) in Patients with Large-Vessels Vasculitis: Single-centre Experience in Paris. American College of Rheumatology Convergence, ACR 2020, Nov 2020, NA, United States. 72 (S10), pp.1-4259, 2020, ⟨10.1002/art.41538⟩. ⟨hal-03831597⟩
  • Océane Landon-Cardinal, Perrine Guillaume-Jugnot, Lois Bolko, Ségolène Toquet, Aude Rigolet, et al.. JAK Inhibitors: A Promising Molecular- targeted Therapy in Dermatomyositis. American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2019, Nov 2019, Atlanta, United States. 71 (S10), pp.1-5420, 2019, ⟨10.1002/art.41108⟩. ⟨hal-03831682⟩
  • Océane Landon-Cardinal, Kuberaka Mariampillai, Céline Anquetil, Aude Rigolet, Baptiste Hervier, et al.. Chronic disease course and ivig-dependance in long-term follow-up of anti-hmgcr immune-mediated necrotizing myopathy. American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2019, Nov 2019, Atlanta, United States. 71 (S10), pp.1-5420, 2019, ⟨10.1002/art.41108⟩. ⟨hal-03831692⟩
  • Camille Houssais, J Noury, Y. Allenbach, L Gallay, F Assan, et al.. Myositis in patients with primary Sjögren’s syndrome: data from a French nationwide survey.. EULAR, Jun 2019, Madrid, Spain. ⟨hal-02152824⟩
  • Céline Anquetil, Joe-Elie Salem, Bénédicte Lebrun-Vignes, Douglas Johnson, Andrew Mammen, et al.. Immune checkpoint inhibitor-associated myositis: a new entity amongst immune inflammatory myopathies with a poor prognosis. IFODS 2019, Jun 2019, Paris, France. ⟨hal-03834301⟩
  • Yves Allenbach, Emmanuelle Salort-Campana, Edoardo Malfatti, Bruno Eymard, Shahram Attarian, et al.. Vacuolar myopathy with monoclonal gammapathy and stiffness: A new Monoclonal gammopathy of muscle significance. GCOM 2019 - Global Conference on Myositis 2019, Mar 2019, Berlin, Germany. , BMC Rheumatology Poster presentation n° P133, 3 (S1), pp.31, 2019, ⟨10.1186/s41927-019-0078-3⟩. ⟨hal-03832060⟩
  • Marion Peyre, Nicolas Champtiaux, Kuberaka Mariampillai, Océane Landon-Cardinal, Mathieu Vautier, et al.. Clinical presentation and outcome in anti-SRP IMNM: french cohort of 54 patients. Global Conference on Myositis 2019 (GCOM 2019), Mar 2019, Berlin, Germany. 3 (S1), pp.31, 2019, ⟨10.1186/s41927-019-0078-3⟩. ⟨hal-03832041⟩
  • Nadège Wesner, Akinori Uruha, Shigeaki Suzuki, Kuberaka Mariampillai, Benjamin Granger, et al.. Anti-RNP antibodies delineate a subgroup of necrotizing myositis. Global Conference on Myositis 2019 (GCOM 2019), Mar 2019, Berlin, Germany. 3 (S1), pp.31, 2019, ⟨10.1186/s41927-019-0078-3⟩. ⟨hal-03832045⟩
  • Gaelle Dzangué-Tchoupou, Yves Allenbach, Corinna Preusse, Werner Stenzel, Olivier Benveniste. Mass cytometry reveals an impairment of B cell homeostasis in Anti-synthetase syndrome. Global Conference on Myositis 2019 (GCOM 2019), Mar 2019, Berlin, Germany. 3 (S1), pp.31, 2019, ⟨10.1186/s41927-019-0078-3⟩. ⟨hal-03832069⟩
  • Mathieu Vautier, Pierre Duffau, Olivier Chosidow, Alice Berezne, Nadege Cordel, et al.. Dermatomyositis associated with antibodies to small ubiquitin like modifier activating enzyme: a retrospective series of 41 cases. Global Conference on Myositis 2019 (GCOM 2019), Mar 2019, Berlin, Germany. 3 (S1), pp.31, 2019, ⟨10.1186/s41927-019-0078-3⟩. ⟨hal-03832029⟩
  • Océane Landon-Cardinal, Kuberaka Mariampillai, Céline Anquetil, Aude Rigolet, Baptiste Hervier, et al.. Chronic disease course and IVIg-dependance in long-term follow-up of anti-HMGCR immune-mediated necrotizing myopathy. Global Conference on Myositis 2019 (GCOM 2019), Mar 2019, Berlin, Germany. 3 (S1), 2019, ⟨10.1186/s41927-019-0078-3⟩. ⟨hal-03832037⟩
  • Kubéraka Mariampillai, Ségolène Toquet, Yurdagul Uzunhan, Gaelle Leroux, Laure Gallay, et al.. Dermatomyositis with anti-MDA5 auto-antibodies: is there a seasonal pattern of disease onset?. Global Conference on Myositis 2019 (GCOM 2019), Mar 2019, Berlin, Germany. 3 (S1), pp.31, 2019, ⟨10.1186/s41927-019-0078-3⟩. ⟨hal-03832031⟩
  • Audrey Aussy, Manuel Fréret, Laure Gallay, Laurent Drouot, Fabienne Jouen, et al.. The IgG2 isotype of anti-transcription intermediary factor 1-gamma autoantibodies is a biomarker of mortality and cancer in adult dermatomyositis. Global Conference on Myositis 2019 (GCOM 2019), Mar 2019, Berlin, Germany. 3 (S1), pp.31, 2019, ⟨10.1186/s41927-019-0078-3⟩. ⟨hal-03832023⟩
  • Alexandrine Mahoudeau, Leandro Ladislau, Yves Allenbach, Thérèse Croughs, Allia Gati, et al.. Evaluation of the effect of neutralizing anti-IFN-α antibodies produced in one SLE patient vaccinated with IFN-K on myotubes atrophy induced by type I interferon. Global Conference on Myositis 2019 (GCOM 2019), Mar 2019, Berlin, Germany. 3 (S1), pp.31, 2019, ⟨10.1186/s41927-019-0078-3⟩. ⟨hal-03832054⟩
  • Barbara Paesler, Laure Gallay, Yves Allenbach, Olivier Benveniste, Nathalie Streichenberger, et al.. Anti-Jo-1 antibody-positive patients show different clinical symptoms, histological features and molecular gene expression compared to anti-PL-7 and anti-PL-12 antibody-positive patients. Global Conference on Myositis 2019 (GCOM 2019), Mar 2019, Berlin, Germany. 3 (S1), pp.31, 2019, ⟨10.1186/s41927-019-0078-3⟩. ⟨hal-03832074⟩
  • Olivier Mangin, Jean Philippe Bertocchio, Yves Allenbach, Gerard Maruani, Pascal Houillier, et al.. Creatinine- and cystatin C-estimated glomerular filtration rate for estimating renal function during inclusion body myositis. Global Conference on Myositis 2019 (GCOM 2019), Mar 2019, Berlin, Germany. 3 (S1), pp.31, 2019, ⟨10.1186/s41927-019-0078-3⟩. ⟨hal-03832035⟩
  • Samuel Knauss, Corinna Preuße, Yves Allenbach, Sarah Leonard-Louis, Mehdi Touat, et al.. The role of dysfunctional T-cells in immune mediated myositis. Global Conference on Myositis 2019 (GCOM 2019), Mar 2019, Berlin, Germany. 3 (S1), pp.31, 2019, ⟨10.1186/s41927-019-0078-3⟩. ⟨hal-03832038⟩
  • Camille Rasmussen, Laure Gallay, Alain Meyer, Delphine Larivière, Sarah Leonard-Louis, et al.. Anti-NXP2 Dermatomyositis: a severe muscle and skin disease. Global Conference on Myositis 2019 (GCOM 2019), Mar 2019, Berlin, Germany. 3 (S1), pp.31, 2019, ⟨10.1186/s41927-019-0078-3⟩. ⟨hal-03832033⟩
  • Audrey Aussy, Maire Chilles, Laurent Drouot, Fabienne Jouen, Christophe Arnoult, et al.. murin model of anti-TIF1gamma dermatomyositis: preliminary results. Global Conference on Myositis 2019 (GCOM 2019), Mar 2019, Berlin, Germany. 3 (S1), pp.31, 2019, ⟨10.1186/s41927-019-0078-3⟩. ⟨hal-03832032⟩
  • Maximilien Sochala, Raphaël Porcher, Tanya Stojkovic, Henri Marc Bécane, Anthony Béhin, et al.. High Risk of Fatal and Non-Fatal Venous Thromboembolism in Myotonic Dystrophy. 6th International Congress of Myology, Mar 2019, Bordeaux, France. ⟨hal-04020135⟩
  • Yves Allenbach, Yurdagul Uzunhan, Ségolène Toquet, Gaëlle Leroux, Laure Gallay, et al.. Moving from Dermatomyositis Associated with Anti-Melanoma Differentiation-Associated Gene 5 Antibody to Anti-Melanoma Differentiation-Associated Gene 5 Syndrome. the 2018 ACR/ARP Annual Meeting, Oct 2018, Chicago, United States. , Arthritis Rheumatol., 70 (suppl 10), pp.Abstract Number: 1331. ⟨hal-02005435⟩
  • Yves Allenbach, Yurdagul Uzunhan, Ségolène Toquet, Gaëlle Leroux, Laure Gallay, et al.. Moving from Dermatomyositis Associated with Anti-MelanomaDifferentiation-Associated Gene 5 Antibody to Anti-MelanomaDifferentiation-Associated Gene 5 Syndrome. American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2018, Oct 2018, Chicago, United States. 70, pp.1-3584, 2018, ⟨10.1002/art.40700⟩. ⟨hal-03831335⟩
  • Yannick Dieudonné, Yves Allenbach, Olivier Benveniste, Sarah Léonard-Louis, Baptiste Hervier, et al.. Granulomatous Myositis: Heterogeneity and Response to Treatment. American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2018, Oct 2018, Chicago, United States. 70, pp.1-3584, 2018, ⟨10.1002/art.40700⟩. ⟨hal-03831339⟩
  • Océane Landon-Cardinal, Damien Bachasson, Perrine Guillaume, Mathieu Vautier, Nicolas Champtiaux, et al.. Physical Activity Monitoring Using Wrist-Worn Accelerometer in theAssessment and Follow-up of Patients with Myositis. American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2018, Oct 2018, Chicago, United States. 70, pp.1-3584, 2018, ⟨10.1002/art.40700⟩. ⟨hal-03831348⟩
  • Céline Anquetil, Joe-Elie Salem, Bénédicte Lebrun-Vignes, Douglas B. Johnson, Andrew L. Mammen, et al.. Immune checkpoint inhibitor-associated myositis: a new and severe entity amongst immune inflammatory myopathies. Global Conference on Myositis 2019 (GCOM 2019), Mar 2017, Berlin, Germany. 3 (S1), pp.31, 2019, ⟨10.1186/s41927-019-0078-3⟩. ⟨hal-03832066⟩

Preprints, Working Papers

  • Bolko Loïs, Celine Anquetil, Alba Llibre, Solene Maillard, Damien Amelin, et al.. Ultrasensitive Interferons quantification in idiopathic inflammatory myopathies serve as biomarkers of activity in dermatomyositis and anti-synthetase syndrome. 2021. ⟨pasteur-03252308⟩

Theses

  • Wladimir Mauhin. Exploration des mécanismes inflammatoires impliqués dans la physiopathologie de la maladie de Fabry et la réponse à l’enzymothérapie substitutive. Médecine humaine et pathologie. Sorbonne Université, 2018. Français. ⟨NNT : 2018SORUS610⟩. ⟨tel-03153269⟩
  • Gaëlle Dzangué Tchoupou. Caractérisation des réponses immunitaires chez les patients atteints de myopathies auto-immunes idiopathiques. Immunologie. Sorbonne Université, 2018. Français. ⟨NNT : 2018SORUS171⟩. ⟨tel-02457144⟩
  • Yves Allenbach. Rôle des lymphocytes T régulateurs dans un modèle murin de myopathie inflammatoire et implications dans la physiopathologie et la thérapie de la Myosite à Inclusions. Immunologie. Université Pierre et Marie Curie - Paris VI, 2011. Français. ⟨NNT : 2011PA066615⟩. ⟨tel-00824661⟩

Assistance Publique Hôpitaux de Paris
Agence nationale de la recherche
RaPharma
The Myositis Association
Association VLM
http://www.snfmi.org/
CSL Behring
The Uehara Memorial Foundation
NeoVacs
Sanofi

You cannot copy content of this page

Share This